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9General introduction and aim of this thesis
The overall aim of the experimental work presented in this thesis was to unravel the 
genetic and cell biological mechanisms that govern myelination in the peripheral 
nervous system (PNS) in order to understand the relationship between congenital 
hypomyelination and joint contractures, as observed in claw paw (clp/clp) mice [1]. 
This mouse mutant faithfully models a neurogenic form of congenital arthrogryposis 
observed in humans [2-7].
The two specific aims of this thesis are: To define in which cell type of the developing 
nerve clp gene function is required and to further define the cell biological and 
developmental defects in clp/clp mice.
   
The myelin sheath is a highly organized structure, formed by oligodendrocytes in 
the central nervous system (CNS) and Schwann cells in the peripheral nervous 
system (PNS). Myelin formation and homeostasis depends on axonal signals, the 
nature of which remains poorly understood [8-12]. The clp/clp mouse is an animal 
model for congenital dysmyelination of the peripheral nervous system. Other mouse 
mutants showing dysmyelination of the PNS include trembler, dystrophic and quaking 
mice. Trembler and dystonia have abnormal myelination exclusively in the peripheral 
nervous system, similar to clp/clp. In contrast, quaking exhibit hypomyelination in 
both the central and peripheral nervous system [13]. However, while in clp/clp mutant 
mice the posture abnormality is detectable within 2 days after birth [1], the other mice 
exhibit limb abnormalities in the second postnatal week [13].
Reciprocal signaling between axons and Schwann cells is required for myelination. 
Therefore, the pathology of dysmyelination alone does not reveal whether axonal 
signals or glial signals are impaired. 
Several experimental approaches have been developed to unravel the interdependence 
of axon and glia in the pathogenesis of dysmyelination. 
Schwann cell differentiation can be monitored during development using in vitro culture 
experiments and nerve regeneration experiments [14]. Although nerve regeneration does 
not mimic nerve development in each single detail [15, 16], it is considered a reiteration of 
development and can be used as an experimental model to study myelination. 
Grafting experiments have been useful to distinguish between axonal or Schwann 
cell defect in trembler, dystrophic and quaking mouse mutants [13]. Therefore, we 
used reciprocal grafting experiments between wildtype and clp/clp mice, to identify 
the cell type (neuron, Schwann cell or both) underlying the claw paw phenotype. 
In addition, we show that clp/clp nerves are delayed at the radial sorting stage of 
nerve development, probably contributing to the previously described congenital 
hypomyelination phenotype. 
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Myelination and Schwann cell differentiation was further studied in the clp/clp mouse 
through analysis of the expression patterns of two pivotal transcription factors involved 
in myelination, namely Oct-6 and Krox-20. In this thesis I further describe our efforts 
to identify the clp mutation through positional cloning.
In summary: Chapter 1 gives a general introduction to regulation of PNS myelination.
Chapter 2 will introduce the experimental work.
Chapter 3 describes the transplantation experiments performed between clp/clp and 
its littermates. 
Chapter 4 describes that expression of myelin proteins involved in polarisation are 
delayed in clp/clp mice. 
In chapter 5 we make a start with the positional cloning of the clp gene using molecular 
biological approach. 
Chapter 6 contains concluding remarks and future perspectives.
General introduction and aim of this thesis
Murad
Hangi dağa tırmansam, muradım otesinde; 
Murad, bugün yerine her günün ertesinde….. 
N. F. Kısakürek (Çile)
Het verlangen
Welke berg ik ook beklim, mijn verlangen ligt steeds weer daar achter,
Het verlangen, iedere keer schuift hij naar de volgende dag….
Vrije vertaling 
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Introduction to myelination
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Myelin structure
Myelin sheath 
Peripheral nerves mainly consist of axons insulated by a layer of myelin. Myelin was 
fi rst  described some 150 years ago by Virchow [17-19]. Many large caliber axons 
(>0.7 μm) in vertebrates are surrounded by a myelin sheath [9, 20]. The myelin 
sheath function is frequently compared with that of the plastic insulation around an 
electric wire. Its principal roles are indeed to reduce the capacitance of the internodal 
axolemma and preventing dissipation of the action potential. However, myelin also has 
very important other functions including structural, mechanical and trophic support to 
the axon [8, 9]. 
Myelin is found in both the central (CNS) and peripheral nervous system 
(PNS) (See Figure 1).
However, the cell type forming this sheath is different in PNS and CNS. 
Oligodendrocytes are the myelinating glial cells in the CNS and Schwann cells in 
the PNS. While oligodendrocytes form a myelin sheath around multiple axons, only 
a single axon is myelinated by a Schwann cell. Despite the fact that each Schwann 
cell has the potency to form a myelin sheath, unknown axonal signals determine 
whether myelination occurs [8, 21, 22]. Non-myelinating Schwann cells ensheath 
multiple axons and provide insulation of slow-conducting nerves (C-fi bres) [23]. While 
oligodendrocytes are not associated with a basal lamina, the latter has a critical role 
in myelin formation by Schwann cells [24, 25]. Although the myelin sheath plays the 
Figure 1. A schematic view of the locomotor apparatus, including central, peripheral nervous system and 
muscle. Myelin is formed in both the central and peripheral nervous system. Schwann cells form myelin 
around axons in the peripheral nervous system. Impulses are generated at the axon hillock of sensory 
neurons in the dorsal root ganglia and conducted rapidly in a saltatory fashion, jumping from node to 
node, along the length of the axon. Adapted from Ho, Annu. Rev. Neurosci. 1998
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same role and has similar biochemical properties in both CNS and PNS, important 
differences between the myelin sheath in the two systems exist. We will focus on 
myelination in the peripheral nervous system. 
Establishment of proper contact between the future myelinating Schwann cell 
and an axon involves the polarization of the cell and elaboration of a basal lamina 
[22]. Next the Schwann cell plasma membrane starts to wrap itself spirally around 
the axon repetitively 5 to 100 times [26], depending on axonal diameter [27, 28]. The 
different structural regions that can be recognized in mature myelin are depicted in 
Figure 2.
Two main types of myelin exist in one and the same internode: compact and non-
compact myelin [8, 22]. The latter is found in the structurally and functionally 
distinct domains called Schmidt-Lantermann incisures (funnel shaped interruptions 
in compact myelin) and paranodal loops (lateral borders of the myelin sheath) [29]. 
Furthermore, the myelin sheath is interrupted at regular intervals along the length of 
the axon at the nodes of Ranvier. However, the basal lamina of adjacent Schwann 
cells are fused, forming a continuous tube of extracellular matrix material enclosing 
outer mesaxon
nucleus
microvilli
basal
lamina
adherens junctions
gap junctions
tight junctions
internode
axon
incisures
inner mesaxon
paranodes
incisures
juxtaparanodes
paranodes
node node
inner mesaxon
Figure 2.  Schematic drawing showing an unrolled myelinating Schwann cell highlighting regions of 
compact and non-compact myelin. This fi gure also shows  the position of tight junctions (green), gap 
junctions (orange) and adherens junctions (blue) found in the myelinating Schwann cell. The paranodal 
and juxtaparanodal regions are depicted in blue, red and green respectively. With permission from the 
author Steve S. Scherer, J Peripher Nerv Syst 2002 and Blackwell publishing
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the entire myelinated axon [29]. The space under the basal lamina at the node 
of Ranvier is referred to as the nodal gap. It contains interdigitating Schwann cell 
microvilli and extracellular matrix molecules [8]. The section between two nodes of 
Ranvier is referred to as the internode. 
Although myelin in the CNS and PNS is very similar, overlapping but not identical 
sets of myelin proteins are found in these two systems [11, 22] (see Figure 3).
Myelin protein zero (P-zero), myelin basic protein (MBP) and peripheral membrane 
protein-22 (PMP-22) are components of compact myelin [22]. Whereas P-zero and 
PMP-22 are exclusively found in the PNS, myelin basic protein is found in both the 
PNS and CNS. Conversely, proteolipidprotein (PLP), myelin oligodendrocyte basic 
protein and oligodendrocyte specific protein are exclusively found in compact myelin 
of the central nervous system. Myelin associated glycoprotein (MAG) and E-cadherin 
are components of non-compact myelin in both CNS and PNS [8].
Nodes of Ranvier
The myelinating glial cells are wrapped around the axon, except at the nodes of Ranvier, 
which are regularly spaced small gaps enriched with channels. 
Clustering of sodium channels and potassium channels in the nodal and 
juxtaparanodal axolemma respectively, effectively restricts generation and regeneration 
of the action potential to the nodal region and results in a saltatory mode of impulse 
propagation along the myelinated nerve fiber. It is generally believed that this 
clustering of ion channels results from specific axon glia interactions that determine 
Compact myelin
OSP
+
-
PLP
+
-
MOBP
+
-
MBP
+
+
PMP-22
-
+
P0
-
+
Cx-32
+
+
MAG
+
+
E-cadherin
+
+
CNS
PNS
Non-compact myelin
Figure 3. The proteins found in compact and non-compact myelin in both central and peripheral nervous 
system are depicted. Compact myelin in the peripheral nervous system contains P0, PMP22, MBP, 
whereas in central nervous system myelin oligodendrocyte basic protein (MOBP), oligodendrocyte 
specific protein (OSP), proteolipidprotein (PLP), and MBP is found. Connexin-32, myelin associated 
glycoprotein and E-cadherin are found in non-compact myelin of both peripheral and central nervous 
system.  Adapted from Steve S. Scherer, J Peripher Nerv Syst 2002
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the development and maintenance of the nodal cyto-architecture [10, 22, 29, 30] 
(Figure 4).
Voltage gated sodium channels are composed of a central pore-forming α-
subunit and two auxillary β-subunits [31]. In addition to voltage gated sodium channels, 
sodium calcium exchangers and (regulators of) sodium/potassium ATP’ases [30] are 
involved in maintaining and restoring the action potential. These channels interact 
with other nodal membrane molecules, such as neurofascin 186 and tenascin, and 
cortical proteins such as ankyrin-G and Spectrin IVB (see Figure 4) [30, 32]. Sodium 
channels are able to form complexes with intracellular and transmembrane proteins, 
stabilize the membrane through linkage with extracellular matrix proteins and are 
involved in intracellular signaling [30]. 
As mentioned earlier, it is generally thought that the clustering of ion channels 
results from interaction with the glial cell. However, there is evidence to suggest 
that this clustering results from axon intrinsic properties. In particular, it was shown 
that clustering of sodium channels occurs in dendrites of retinal ganglion cells in 
the absence of glial cells [33]. In addition, internodal distances are constant along 
Figure 4. A schematic drawing of nodes, paranodes and juxtaparanodes, including the possible molecular 
interactions. With permission from the author Steve S. Scherer, J Peripher Nerv Syst 2002 and Blackwell 
publishing
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individual axons and ankyrin-G clustering occurs prior to sodium channel clustering 
implicating axonal properties [10]. On the other hand, sodium channels can be seen to 
cluster at the progressing hemi-node during development, as if the sodium channels 
are being mopped up by the myelinating glia cell [11, 34]. 
Thus, specific glial-axon interactions orchestrate the development and 
maintenance of the nodal, paranodal and juxtaparanodal domains. These interactions 
are mediated through a host of adhesion molecules, some of which are known. The 
correct cytoarchitecture of the node of Ranvier is essential for proper, saltatory 
impulse propagation [30].
 
The paranodes and juxtaparanodes
The saltatory propagation of action potential does not only require intact nodes, but 
also paranodes. At the paranodes the lateral loops of the myelin sheath (paranodal 
loops) touch down on the axolemma to form the axo-glial junction as illustrated in 
Figure 5, which resemble, structurally and functionally, invertebrate septate junctions 
[22, 29, 35]. 
Although septate junctions are comparable with vertebrate tight junctions, septate 
junctions allow diffusion of molecules of low molecular mass (5 kDa) into periaxonal 
space. Similarly diffusion is possible through septate like axo-glial junction into the 
periaxonal space, allowing signalling between glia and axon [10, 22, 24, 29, 35]. 
Adhesion of the paranodal loops to the axonal membrane occurs via adhesion 
molecules present in both the axonal and Schwann cell membrane. Molecules which 
are involved in the forming of paranodes are, at the axonal side, Contactin [36, 37], 
Contactin associated protein (Caspr) and, at the glial side, Neurofascin 155 [38] 
Figure 5. An illustration of axo-glial junction is depicted. These septate-like junctions are progressively 
formed at paranodes with the recruitment of Caspr/contactin and Neurofascin 155. Furthermore the 
proteins involved in the formation of juxtaparanodes and nodes are also depicted. With permission from 
the author E. Peles, Current Opinion Neurobiology 2002 and Elsevier.  
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(figure 4). Indeed, homozygous deletion of the Contactin gene disrupts attachment of 
the paranodal loops to the axolemma, resulting in paranodal loops pointing away from 
the axolemma. As a consequence, potassium channels directly juxtapose sodium 
channels resulting in altered physiological properties of the nerve fiber and reduced 
conduction velocities [36]. 
During development, the sodium channel subtypes expressed at the node 
undergo a transition from Nav1.2 (immature nodes) to Nav1.6 (mature nodes).
In Caspr deficient mice, paranodal loops detach and retract, the nodes are 
widened and immature sodium channels (Nav1.2) are found in the CNS, whereas only 
minor differences in the paranode are found in the PNS. In addition, the transition of 
sodium channel isoforms from Nav1.2 to Nav1.6 is transiently delayed in PNS, whereas 
this transition does not occur in CNS of Caspr-deficient mice. Furthermore, potassium 
channels in the PNS are localized at the paranodes instead of juxtaparanodes (as 
in contactin-deficient animals), whereas in the CNS a transient mislocalization is 
observed in caspr-deficient mice [39]. 
In summary, paranodes regulate the transition of channel subtypes and provide 
a barrier for lateral diffusion of ion channels [34]. Therefore, paranodal junctions 
prevent the dispersion of channels and maintain the proper high concentration of 
sodium channels at the nodes and potassium channels at the juxtaparanodes [39]. 
Schmidt-Lantermann incisures
Recent work has elucidated that membranes of both Schmidt-Lantermann incisures 
and paranodes are similar, containing tight junctions, adherens junctions and gap 
junctions [40]. While at the paranodes adhesion molecules provide tight axo-glial 
interactions, Schmidtt-Lantermann incisures enable rapid cytoplasmic communication 
from the outermost (abaxonal) to innermost (adaxonal) cytoplasmic compartment 
of the Schwann cell via gap junctions (see Figure 6). It was hypothesized that the 
presence of gap junctions in the Schmidt–Lantermann membranes provides a 
direct radial pathway for metabolites and signal exchange, thus short cutting the 
circumferential route [41, 42]. To determine whether these channels indeed provide 
a radial pathway across the myelin sheath, thus diminishing the molecular transport 
distance, dye transfer studies were performed on freshly isolated myelinated fibers. 
The Schmidt-Lantermann incisures were stained when the dye front moved down 
the myelin sheath and this diffusion could be blocked with a drug interfering with the 
opening of gap junctions [41, 42]. Consistent with this observation, it was suggested 
that in patients suffering from the X-linked form of Charcot-Marie Tooth (CMTX), where 
mutations are found in connexin-32, this radial pathway is impaired resulting in longer 
transport routes and hence demyelination and axonal loss. Surprisingly dye studies 
performed on myelinating Schwann cells of connexin-32 null mice did not provide the 
21
Introduction to myelination
expected answer. Instead they showed a similar pattern to the wildtype, suggesting 
that one or more other gap junction protein are present and fullfill this function [29, 41, 
42]. Although the suggestion that connexin mutations might impair the radial pathway 
is a plausible explanation for demyelinating neuropathies within some families, it does 
not clarify axonal neuropathies in other families. Some authors have suggested a 
misclassification of the disease [43]. Others have proposed that abnormal properties 
of functional channels, for example altered voltage gating [44], may underlie the 
pathology of CMTX. Nevertheless connexin-32 is one of the gap junction proteins 
found at paranodes and Schmidtt-Lantermann incisures, providing a link between the 
abaxonal and adaxonal cytoplasmic compartment within the Schwann cell [30]. 
Basal lamina
The differentiation of Schwann cells into myelin and non-myelin forming cells 
involves the polarisation of the cellmembrane into an adaxonal (directly contacting 
Figure 6. A schematic picture of a peripheral myelinated nerve fibre. Both longitudinal and cross sections 
are illustrated, demonstrating the different regions such as paranodes, juxtaparanodes, microvilli, 
Schmidtt-Lantermann incisures. Furthermore, the inner mesaxon and outer mesaxon is depicted. With 
permission from the author James L. Salzer, Neuron 2003 
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the axolemma) and an abaxonal domain. As part of this process, a basal lamina is 
deposited by the Schwann cell at it’s abaxonal surface. The formation of a basal lamina 
is important for subsequent cellular differentiation [25, 45, 46], in particular myelination, 
as myelination is delayed in its absence [47]. 
The basal lamina is continuous along the length of the myelinated fiber and 
non-myelinated Remak fiber. Major components of the basal lamina are the laminins. 
Laminins provide an essential function in assembling the other components of basal 
lamina into a tight network. These other components include molecules such as 
type IV collagen, fibronectin, glypican, N-syndecan and entactin [8, 48]. In addition, 
laminins are important ligands for cell surface receptors such as the integrins and 
dystroglycan [8, 48], thus linking the basal lamina to essential processes such as 
cellular proliferation, differentiation, migration and morphology [47, 48]. 
Each laminin molecule consists of three subunits, α, β and γ chains. Laminin-
2 (α2β1γ1) also referred as merosin (s-laminin) is a major constituent of basal lamina 
in muscle and peripheral nerve. In the peripheral nerve the basal lamina is linked to 
the actin cytoskeletal network via dystroglycan, dystrophin related protein (DRP2) and 
L-periaxin (myelin protein required for maintenance of myelin integrity) as indicated in 
Figure 7 [26, 49].
 
Sarcoglycans
Basal lamina
Laminin-2
dystroglycan
Dp116DRP2DRP2
F-actin
L-periaxin
Utrophin
Figure 7. A schematic picture of the Schwann cell basal lamina and the possible molecular interactions. 
Laminin-2 is linked to α- and β-dystroglycan which in turn is linked to dystrophin related protein and 
periaxin. With permission from the author Steve S. Scherer, J Peripher Nerv Syst 2002 and Blackwell 
publishing
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Myelination of the peripheral nervous system
Initiation of myelination; axonal components
During embryonic development axons navigate through the embryonic environment 
to reach their target organs. A part of establishment of such a complex network as the 
peripheral nervous system is the directed growth of the axon to its target. Pathfinding 
of migrating axons and the forming of connections in the developing nervous system 
is controlled via attractive, repulsive and permissive cues. For example neurotrophins, 
ephrins and extracellular matrix molecules (laminins) are associated with axonal 
guiding. Either they act via specific receptors or bind to specific cell adhesion 
molecules. Integration of these attractive and repulsive signals occurs at the tip of the 
growing axon, referred to as the growth cone, resulting in cytoskeletal changes of the 
axon and hence in neuronal polarity [50]. In addition to extracellular matrix molecules 
and diffusible molecules, it has been shown that also neuronal activity plays a role 
in axon guidance as analysed in Xenopus spinal neurons. It was demonstrated that 
electrical stimulation of neurons could turn attractive impulses into repulsive ones and 
vice versa [51]. 
Axonal outgrowth precedes and regulates Schwann cell survival and 
differentiation.  Genetic and cell culture experiments have demonstrated that survival 
of Schwann cell precursors depends on axonally derived factors encoded by the 
Neuregulin1 gene [52-55]. This gene encodes, through alternative splicing, a number 
of proteins that can be grouped in three structurally related isoforms, called type 
I to III. The neuregulin isoform that acts as a cell survival factor for Schwan cell 
precursors is the ‘sensory and motor neuron derived factor’ (SMDF). The effects of 
Neuregulin isoforms are mediated through the hetero-dimeric receptor ErbB2/ErbB3 
which is expressed on the Schwann cell membrane [52, 53]. In Neuregulin1 knock-
out mice, Schwann cell precursors do not survive. Schwann cell precursors also die 
in ErbB2 and ErbB3 [56] knock-out mice. While it is unlikely that neuregulins play a 
role in the initiation of myelination, recent evidence establish a role for neuregulins in 
the extent of myelination, that is the number of myelin wraps elaborated around the 
associated axon [57]. It has been known for a long time that myelin is only formed 
around axons with a diameter larger than 0.7 µm and that the number of myelin wraps 
correlates with axonal diameter [58]. With the identification of neuregulin as one 
important regulator of myelin thickness, a significant step forward in understanding 
myelination has been made.
Axon calibre largely depends on neurofilaments (NF) and microtubules, 
major components of the axonal cytoskeleton [59]. While microtubules are found in 
immature axons, maturation of axonal calibre is associated with neurofilament and 
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in particular with phosphorylation of neurofilaments [60]. The phosphorylation state 
of neurofilaments, and thus the diameter of the axon, depends on myelination [61]. 
Therefore, reciprocal signalling between the Schwann cell and the axon determines 
axonal calibre and myelin thickness.    
Despite extensive studies, it is still unclear how axons initiate the myelination 
program. But a correlation with action potentials [62], secretion of diffusible molecules 
and axonal diameter has been made.
Schwann cell development and differentiation
Schwann cell development and differentiation has been studied extensively, using 
modern and classic experimental approaches, including cell culture, nerve surgery, 
transgenesis and gene knock-out technology. Schwann cells develop from the neural 
crest, a transient migratory population of pluripotent embryonic cells that originates 
from the dorsal aspect of the neural tube. These migrating neural crest cells invade 
and populate the outgrowing embryonic nerve bundle and differentiate into Schwann 
cell precursors. These Schwann cell precursors further differentiate through a series of 
well-defined stages to give rise to the two mature Schwann cell phenotypes observed 
in the adult peripheral nerve tissue; the myelinating and non-myelinating Schwann cell. 
Neural crest cells do not only give rise to Schwann cells but also to neurons of the 
peripheral and enteric nervous system,  endocrine cells, bone, cartilage, connective 
tissue, pigment cells and additional glia cell types such as the satellite cells of sensory 
neurons and the glia cells of the enteric nervous system [63, 64].
Schwann cell precursors migrate and proliferate along the outgrowing 
nerve bundles. These cells subsequently invade the bundles with their cytoplasmic 
extensions and segregate fibers into individual axons or families of axons, in a 
process referred to as radial sorting. While a prospective non-myelinating Schwann 
cell ensheaths multiple lower calibre axons, a prospective myelinating Schwann cell 
segregates axons until a one to one ratio is achieved. 
Three major transitional stages can be distinguished in the differentiation of 
a Schwann cell; the transition of a migrating crest cell to a Schwann cell precursor 
(around embryonic day 9/10 E9/10), from precursor to immature Schwann cell (which 
occurs around E13 in mouse and E15 in rat) and finally the reversible formation of 
mature myelinating and non-myelinating Schwann cells (around birth and the first 
postnatal week) [65] (figure 8). These different stages are defined by a number of 
morphological criteria, expression of marker proteins and growth factor dependence 
in culture [21, 66]. For example, Schwann cell precursors express the low affinity 
neurotrophin receptor p75 and depend on Neuregulin for their survival in culture. 
Immature Schwann cells can be distinguished from precursors on the basis of 
expression of growth associated protein-43 (GAP-43) and their independence of 
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neuregulin for survival in vitro. Premyelinating and promyelinating Schwann cell are 
characterized by the expression of Oct-6 and, one day later, by expression of Krox-20 
[67].  
In order to gain a deeper understanding of the molecular interactions between 
neurons and Schwann cells, it is important to identify the molecular components of the 
myelination program and to study the interaction of these components with each other 
and other factors that drive myelination. Among the genes involved in the differentiation 
of Schwann cells, the transcription factors Oct-6 and Krox-20 are extensively studied 
and have been shown to play important roles in the genetic cascade of myelination.
Expression of both factors requires direct axonal contact. 
Initiation of myelination; Schwann cell components
Oct-6
Transcription factors are also referred to as trans-acting factors. This term refers to 
the fact that transcription factors regulate expression of other genes, through binding 
to cis-acting sequences, such as enhancers, silencers and promoters present in the 
target gene locus [68]. Transcription factors are in general modular in stucture and 
can conveniently be thought of as consisting of several covalently linked functional 
Immature
Schwann cell
Krox-20
Fetal Postnatal
Oct-6
P0
Neural crest
cell
Schwann cell
precursor
Pro-myelinating
Schwann cell
Myelinating
Schwann cell
Periaxin
Figure 8. A schematic picture of Schwann cell differentiation and temporal expression of a number of 
relevant genes. Among these proteins, Oct-6 and Krox-20 are transcription factors and periaxin and P0 
are myelin proteins. 
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domains. One important functional domain of the transcription factor is the DNA 
binding domain. DNA binding domains are variations on several structural motifs such 
as the helix-turn-helix motif found in all types of homeodomain proteins and the zinc-
finger domain, a finger-like structural motif that binds a Zn2+ atom. The POU (Pit-1, 
Oct-1/2 and Unc-86) domain consists of a POU specific domain linked through a short 
peptide sequence to a homeodomain, specific for this class of proteins. Both the POU-
specific domain and the POU homeodomain are structural variations of the helix-turn-
helix motif. Thus, the POU domain consists of two DNA binding domains tethered 
by a short linker. As a consequence, POU domain proteins bind to a bipartite DNA 
sequence which are variations on the octamer sequence, ATGCAAAT, first described 
to be an essential part of the immunoglobulin gene promoter and enhancer [69]. 
Members of the POU domain protein family play important roles in cell specific gene 
regulation during embryonic development, in particular in the nervous system [69, 70]. 
One of these POU proteins is Oct-6 (also referred as ‘suppressed cAMP inducible 
POU’ (Scip) or Testis 1 (Tst1; official MGI name; Pou3f1) [71]. This transcription 
factor is expressed in embryonic stem cells, testes, epidermis and in myelinating 
cells, both oligodendrocytes and Schwann cells [72]. In cultured rat Schwann cells, 
Oct-6 expression is up-regulated by agents that increase intracellular cyclic AMP 
(cAMP) concentrations such as Forskolin, a reversible activator of adenylyl cyclase. 
A similar upregulation was observed for the myelin proteins P-zero and P2. Therefore 
it was assumed that Oct-6 might be involved in regulation of myelin gene expression. 
However, it was found that Oct-6 is most abundantly expressed in promyelinating 
Schwann cells and is rapidly downregulated once myelination starts [69, 72, 73]. 
Furthermore, cotransfection studies in cultured rat Schwann cells, demonstrated that 
Oct-6 strongly represses the promoters of the P-zero and MBP myelin genes and 
p75NTR gene [74, 75]. This suggested an alternative role for Oct-6 as a repressor of 
myelin gene expression. It was hypothesized that downregulation of Oct-6 results 
in derepression of myelin gene expression and initiation of myelination. To test this 
hypothesis, Weinstein and colleagues sought to define a system in which Oct-6 could 
be specifically inhibited in Schwann cells. Their cotransfection data suggested that a 
truncated form of Oct-6, essentially consisting of the POU domain, inhibits repression 
of myelin gene promoters by Oct-6. Therefore, they generated a transgenic mouse 
expressing the truncated Oct-6 (referred to as ΔSCIP) from a rat P-zero promoter. 
The logic of this approach is twisted as it is expected that Oct-6 will repress the P-
zero promoter. Moreover, it was known that P-zero is already expressed, although at 
low levels, in Schwann cell precursors and one could therefore expect expression of 
the transgene well before the beginning of myelination [76]. Nevertheless, transgenic 
mice were obtained that exhibit premature myelination and hypermyelination of 
the peripheral nerves [77]. However, their conclusion that indeed Oct-6 serves as 
27
Introduction to myelination
a repressor of myelin genes and that downregulation of Oct-6 initiates myelination 
contradicts evidence obtained through analysis of the developmental peripheral 
nerve phenotype in mice in which Oct-6 is homozygously deleted [78, 79]. Mice 
homozygous for the disrupted Oct-6 allele usually die within 2 hours after birth due to 
breathing problems, although some survive for several days, weeks or, in rare cases, 
even for months. Oct-6 mutant mice exhibit delayed onset of myelination of peripheral 
nerves with a transient arrest of Schwann cell differentiation at the promyelin stage. 
Myelination of the central nervous system by oligodendrocytes appears normal [78, 
79]. This suggests that Oct-6 is not directly involved in myelination, but is required 
for progression from the promyelin into the myelinating stage of Schwann cell 
differentiation [78, 80]. 
The highly dynamic and diverse expression pattern of Oct-6 suggests the 
existence of a collection of complex enhancers within the Oct-6 locus [81]. In general, 
cell specific gene expression is governed by tissue specific promoters or other 
regulatory sequences such as enhancers which are the target of transcription factors 
and intra- and extracellular signalling pathways. As Schwann cell specificity was 
found not to be solely associated with the Oct-6 promoter, other regulatory regions 
were suspected to be involved. Using a deletion mapping approach in transgenic 
mice, a minimal cis-acting element was characterized, which was required to activate 
the Oct-6 gene expression in Schwann cells [82]. This element (Schwann cell specific 
enhancer (SCE)) was found to be sufficient to drive the Oct-6-dependent myelination. 
Hence, it was expected that deletion of the SCE would result in a Schwann cell 
specific Oct-6 null allele. To test this hypothesis, mice were generated in which the 
SCE was deleted. Indeed, deletion of the SCE only affected Schwann cell specific 
expression of Oct-6 without affecting the expression of Oct-6 in regions such as the 
hippocampus, brainstem nuclei and retina [15]. As the peripheral nerve phenotype in 
Oct-6 null mice and ΔSCE null mice is similar, this experiment also formally proves 
that Oct-6 is cell autonomously required in Schwann cells to drive the differentiation 
of these cells [15].
In summary, Oct-6 is cell autonomously required in Schwann cells to drive the 
cells through the promyelin stage of cell differentiation. 
Krox-20
Krox-20 (Early growth response gene = Egr-2) is part of a multigene family encoding 
zinc finger transcription factors, and may play a role in the regulation of cellular 
proliferation. Krox-20 was identified as an immediate-early response gene that binds 
DNA in a sequence specific manner and is required for myelination of peripheral 
nerves. During mouse development Krox-20 is expressed in rhombomeres 3 and 5 
(r3 and r5) of the segmented hindbrain, in immature and myelinating Schwann cells, in 
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hypertrophic chondrocytes and differentiating osteoblasts [83] and in hair follicles. In 
the adult, Krox-20 gene expression is maintained at low levels in myelinating Schwann 
cells, in bone and in specific neuronal populations of the cortex [84]. The expression 
pattern of LacZ (encoded by the b-galactosidase gene that was knocked in the Krox-
20 locus) in Krox-20βgeo/βgeo mice, indicated that hindbrain segmentation is affected 
and that expression in boundary cap cells (glial cells) is confined to the motor and 
sensory roots of cranial and spinal nerves from embryonic day 10.5 (E10.5) till E14.5 
[84]. It was remarkable to see that Krox-20 expression was restricted to boundary cap 
cells till E15.5. A transition occurs at day E15.5 when Krox-20 expression is detected 
along the peripheral nerve [84]. 
Thus, one of the questions was how Krox-20 expression is regulated from 
E10.5 till E15.5. This could be due to axonal factors, for example a soluble factor 
secreted during that time period. Cell culture experiments were performed in which 
E12.5 dorsal root sensory neurons  were placed in culture together with Schwann cells 
derived from newborn mice  heterozygous for the Krox-20/LacZ allele [67]. Indeed, 
sensory neurons were capable of inducing Krox-20 expression, suggesting that axons 
(E12.5) already have a signal to induce Krox-20 expression in Schwann cells. That 
Krox-20 is integral to the myelination program, was supported by experiments in which 
Krox-20 was expressed in cultured rat Schwann cells from a viral promoter. Using 
micro-array analysis of such transfected cells it was shown that Krox-20 induces 
expression of myelin genes, including P0, periaxin and myelin basic protein [85]. 
This study shows that Krox-20 influences expression of genes involved in Schwann 
cell differentiation, such as the cytoskeletal protein dendrin, cell adhesion molecules, 
laminin, integrin and genes involved in lipid metabolism. 
Ghislain and colleagues [86] identified Schwann cell specific regulatory 
elements within the Krox-20 locus. Two specific cis-acting elements governing 
Schwann cell specific expression of Krox-20 were identified; the immature Schwann 
cell element (ISE) and the myelinating Schwann cell element (MSE) [86] (Figure 9). 
The latter element required the POU domain transcription factor Oct-6 at the time of 
myelination, consistent with the observation that Krox-20 expression is delayed in Oct-
6 mutant Schwann cells. However, the activity of the former element (ISE) does not 
require Oct-6 [86], indicating that there could be another factor, probably parallel to 
Oct-6 and Krox-20, which could initiate myelination. Recently Jaegle and colleagues 
identified Brn-2 as the factor that can partially fullfil Oct-6 function in Schwann cell 
differentiation [87]. 
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Oct-6 and Krox-20 null phenotypes
Analysis of both the Oct-6 and Krox20 mouse mutants was hampered by the early 
postnatal death of homozygous knock-out pups. While Oct-6 knock-out mice are 
characterized by a smaller size and exhibit occasional tremors, surviving Krox-20 null 
mice tremble. The appearance of Oct-6 protein in Schwann cells precedes Krox-20 
by 24-48 hours and, as discussed above, probably directly regulates Krox-20 gene 
expression through interaction with the myelinating Schwann cell element (MSE). 
In the peripheral nervous system of both Oct-6 and Krox-20 null mice, a one to one 
ratio of axon and Schwann cell is established and a normal basal lamina is formed. 
Whereas promyelin figures in Oct-6 null mice diminish in time (arrest is transient), 
in Krox-20 null mice promyelin figures are maintained. Thus while myelination is 
transiently delayed in the Oct-6 null mouse, virtually all axons in Krox-20 null mice 
remain devoid of myelin [78, 79, 84]. See table I. However, it should be kept in mind 
that Krox20 mice do not survive beyond the third week of postnatal life.
?
Figure 9. A Schwann cell has surrounded an axon, the presence of a basal lamina indicates myelination. 
Within the Schwann cell the genetic cascade involved in myelination is depicted. Unknown axonal signals 
initiate Oct-6 expression, in turn regulating Krox-20 gene expression via the recently identified MSE 
(myelinating Schwann cell element). Krox-20 is regulating the upregulation of many genes including 
myelin genes such as P0, periaxin and myelin basic protein. Adapted from W. Mandemakers [116] 
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The claw paw mouse
Claw paw phenotype
28 years ago Nelda Blaisdell observed abnormal front limbs within an inbred strain of 
C57Bl/6J-obese(ob) mice [1]. The limbs, predominantly forelimbs, were held flexed 
at one or more joints, but extended at the elbow [1]. This phenotype was therefore 
called claw paw (clp/clp) [1]. In addition to the limb abnormalities, peripheral nerve 
abnormalities were detected. These were the only abnormalities found. Other tissues 
such as skeletal muscle, bone and joints were normal. However, a slight difference 
was observed in the radial and ulnar bones, which were thinner and straighter in claw 
paw mice. 
Mutant mice could be recognized shortly after birth. The trait was crossed 
out of the obese background onto a C57Bl/6J and it was established that it was 
inherited in an autosomal recessive pattern. The severity of the posture abnormality 
correlated with the course of specific behavioral deficits such as impaired movement 
(mice rather slither) around the cage and an unfavorable position with respect to the 
littermates when competing for milk or food [1]. 
During the early life of clp/clp mice no fixed deformities are found, while in time 
contractures develop [1] (Figure 10).
If clp/clp mice survive the first several weeks of age, their condition variably improves 
and they have a normal lifespan. Contrary to males, who breed poorly, females 
breed successfully [1]. Based on linkage analysis, the clp gene [1] was mapped to 
chromosome 7, in the vicinity of Gpi-1 locus. 
Figure 10. A photo of a wildtype 
and clp/clp mice at postnatal day 
6. Note the limbs, which are held 
along the thorax.   
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Analysis of clp/clp nerves showed a delay in myelination, resulting in 
hypomyelination and promyelin figures throughout the peripheral nervous system that 
persist into adulthood [1]. Nerves at brachial and lumbosacral levels were similarly 
affected and no obvious correlation between limb deformity and nerve pathology 
was found. However, promyelin fibers were more prominent in those nerves which 
normally contain many small caliber axons, such as spinal dorsal roots and cranial 
nerve V [1], than in nerves that normally contain mainly large fibers, such as spinal 
ventral roots and cranial nerve VII. Additionally, both endoneurial connective tissue 
and fascicular subdivision of nerves (small fascicles) are increased (Figure 11).  
The absence of onion bulb structures, and other pathological characteristics 
of demyelinating disease, in clp/clp nerves suggest that the presence of promyelin 
figures results from a developmental defect and not from cycles of de-myelination and 
re-myelination [1].  In summary, these data indicate that clp is a spontaneous mutation 
on chromosome 7 near the Gpi-1 locus, which causes an autosomal recessively 
inherited disorder, resulting in limb posture abnormality and delay in myelination 
within the peripheral nervous system. 
Seven years after description of the claw paw phenotype by Henry, this 
mouse model was selected to study the complex signaling mechanism between axon 
and Schwann cell during nodal development. Earlier studies on development of the 
node suggested that formation and localization of the node along the length of the 
nerve, results from a complex interplay between the axon/neuron and the Schwann 
Figure 11. Electronmicroscopic 
picture of a clp/clp peripheral 
nerve at postnatal day 8. Note the 
hyperplasia of the endoneurium, 
minifascicles and promyeline 
figures. 
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cell (see previous section). The delayed myelination in clp/clp mice provided an 
opportunity to study node formation and sodium channel clustering in the absence 
of myelin during early postnatal development [88]. Since Mag expression precedes 
sodium channel clustering at the node, nodal development was visualized via whole 
mount immunohistochemistry of nerve fibers, with antibodies against Mag and sodium 
channel [88]. While in nerve fibers from P14 heterozygous mice, sodium channels 
were concentrated at the nodes diffuse staining along the clp/clp nerve fibers was 
observed suggestive of delayed myelination and node formation [88]. Sodium channel 
clustering was restricted to the end of myelinating clp/clp Schwann cells. Thus, nodal 
development is delayed in clp/clp nerves. In addition the internodes were short in 
clp/clp nerves [88]. 
The defect in clp/clp appears to involve early Schwann cell axon interactions. 
Since the gene for Mag is located on mouse chromosome 7 in the vicinity of Gpi-1 
(clp) and Mag is assumed to be involved in early axo-glial interactions, it represented 
a likely candidate gene. However, Mag was normally expressed at the mRNA level 
in clp/clp nerves and no altered form of Mag was found [89]. Furthermore, the Mag 
knock-out phenotype did not resemble the claw paw phenotype [90, 91] as it displayed 
only subtle ultrastructural abnormalities of myelin without affecting peripheral nerve 
development. It is therefore very unlikely that clp is an allele of the Mag gene.
In a more recent study clp/clp nerves were used as a dysmyelinating mouse 
model and compared with Oct-6 null mutants in the search for genes regulated by 
Oct-6. In situ hybridization of clp/clp nerves revealed reduced mRNA expression of 
myelin associated genes, including dendrin (a protein of unknown function found in 
dendrites of the neuron), CRP2 (LIM-domain protein, binds to components of actin 
cytoskeleton) and P2 (fatty acid transport protein). However, mRNA expression of P0 
seems to be unaffected, although the nerves are thinner [92]. 
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Chapter 1
Comparison with other mouse mutants and human diseases
A better understanding of myelination in health and disease can be achieved by 
comparison of different mouse models for myelination disorders. In table 1 we have 
compared claw paw with other mouse mutants. Similar to Oct-6 and Krox-20 mutant 
mice, clp/clp mice are characterised by congenital hypomyelination and delayed onset 
of myelination in the PNS indicating that the clp gene is part of the genetic hierarchy 
that controls myelination and includes the Krox20 and Oct-6 genes.
Although promyelin figures are observed in Oct-6 null, Krox-20 null and 
P-zero null mice, limb abnormalities characteristic for clp/clp are not observed in 
these mutants. Instead posture abnormality is observed postnatally in mice lacking 
the kinesin protein KIF1B. However, the observed progressive neurodegeneration 
and impaired central nervous system myelination characteristic for KIF1B mutant, is 
absent in clp/clp mice. 
The genes involved in dysmyelination in mouse have human homologues 
involved in different sorts or neuropathies in humans (table 2).
In humans any disruption resulting in decreased fetal mobility, either intrinsic or 
extrinsic to the developing fetus, could give rise to arthrogryposis multiplex congenita 
[2, 3, 7]. Only a few within this heterogeneous group are neurogenic in origin and 
some are associated with Schwann cell defects [4, 5]. 
The heterogeneous group of human diseases referred to as Charcot Marie 
Tooth (CMT) or hereditary motor and sensory peripheral neuropathy (HMSN) (table 2) 
is a general name for both sensory and motor neuropathies. Its inheritance is diverse 
but mainly autosomal dominant. The peripheral neuropathy can be due to neuronal 
(axonal) damage, Schwann cell defect (demyelinating) or both. Since disruption 
of the myelin layer affects saltatory propagation and other axonal characteristics, 
a Schwann cell defect is generally associated with reduced nerve conduction 
velocities, whereas a neuronal defect does not initially affect the conduction velocity. 
Thus, based on electrophysiologic parameters, CMT is classified as either an axonal 
or demyelinating neuropathy. Although this classification is clinically very useful, it 
does not contribute much to the understanding of the cellular and genetic disease 
mechanisms that underlie the neuropathy. For example, based on clinical, genetic 
and electrophysiological characteristics it is not possible to distinguish between two 
types of severe neuropathies in children: Dejerine-Sottas (DSS) and congenital 
hypomyelination (CH). 
Congenital hypomyelination is a very rare form of neuropathy, which 
presents at birth with profound hypotonia, areflexia, contractures [107] and little 
or no development of peripheral myelin [104, 108, 109]. Usually these patients die 
because of feeding difficulties or respiratory distress. However, some do survive 
and spontaneous improvement of the motor function with increasing age is reported 
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by several authors [44, 110-113]. In humans, CH is associated with mutations in P0 
[104, 114], EGR-2 [102], PMP22 [115] and MTMR2. Dysmyelination of the central and 
peripheral nervous system is observed in most cases. Mutations in Egr-2 or P0 are 
also found in children diagnosed with Dejerine-Sottas syndrome. Neuropathology is 
the only tool for clinicians to distinguish CH from DSS syndrome. Reduced myelination 
of peripheral nerves and absence of onion bulbs (found in DSS) characterize 
CH syndromes [104, 107]. Taken together, the absence of onion bulbs, reduced 
myelination and progressive clinical improvement in these patients is strikingly similar 
to the neuropathology and disease course observed in clp/clp mice. Similarly, clp/
clp mice exhibit hypomyelination throughout the peripheral nervous system, absence 
of onion bulbs and improvement of the disorder when these mice survive the first 
several weeks. Therefore claw paw can be considered a mouse model for hereditary 
peripheral neuropathy in particular CH, which is associated with arthrogryposis. 
These findings emphasize once more the dependence and intimate cellular 
interactions of Schwann cells and neurons, predominantly during development, but 
also in adult life. In the previous pages, I have tried to illustrate the interdependence of 
axons and Schwann cells and the influence of one cell type on the other. Understanding 
the claw paw pathogenesis could shed light on the processes involved in congenital 
hypomyelinating syndrome and arthrogryposis multiplex congenita. To elucidate the 
claw paw phenotype we asked ourselves two main questions:
1) Which cell type underlies the claw paw phenotype (Schwann cell, neuron or 
both), and is Oct-6 expression during Schwann cell differentiation impaired in 
clp/clp nerves
2) Which gene is affected in this mouse model. 
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Introduction to grafting experiments
Nerve grafting is a surgical procedure in which a nerve segment is transplanted from 
one animal to the other. Nerve grafting experiments can create a situation in which 
the regenerating axons of the host contact genetically distinct Schwann cells and thus 
could provide insight in the cell autonomy of genes that affect neuron-Schwann cell 
interactions.
 Axonal damage via crush, transection, ischemia or inflammation results in 
a process referred to as Wallerian degeneration (WD). WD is a process in which 
the axon and its associated myelin disintegrate distal to the site of the insult. As a 
consequence of WD axonal changes, Schwann cell and other neural cell responses 
are observed. 
Axonal changes
Although the signal that initiates WD is unknown, there is evidence that a neuronal 
factor is essential for the maintenance of the myelinating phenotype of the Schwann 
cell [1-3]. Due to this axo-glial disruption, distal and proximal nerve stumps retract. 
Axoplasm leaks out, axons fragment and disappear. This process occurs in an interval 
of many hours to a few days. The structural breakdown of the axon directly (within 24 
hours) impairs the generation and conduction of nerve action potentials. It is believed 
that intra-axonal calcium concentrations rise after nerve transection throughout 
the distal stump [4, 5]. Furthermore, nerve transection results in accumulation of 
transported molecules on both sides of the lesion, involving both anterograde and 
retrograde transport. Because of disruption of the established neuron-Schwann cell 
relationship, myelin sheaths break up, starting at the nodes, into so called ovoids. 
Macrophages, recruited to the site of the lesion, remove myelin ovoids (myelin is a 
potent inhibitor for neural outgrowth) and axonal debris by phagocytosis and hence 
create a new environment for regeneration [2, 3, 6, 7]. 
Subsequently, within a few hours after injury, axons give rise to sprouts, 
each tipped with a growth cone. The growth cone actively searches for a suitable 
matrix and environment, the so-called Schwann tubes (Schwann cells and their basal 
laminae=endotubes). One of these sprouts will grow towards the target via these 
Schwann tubes. Hence, successful axonal regeneration depends on the interaction 
between axons and glial cells [8] within Schwann tubes. These observations raised a 
number of clinically important questions such as; are these endotubes required during 
regeneration and if so which components are active in promoting axon elongation. 
Several studies have revealed that axons prefer endotubes with Schwann cells in situ 
and that in the absence of Schwann cells, extracellular matrix molecules promote 
regeneration only modestly. 
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Schwann cell changes
After axonal damage, expression of late myelin genes is downregulated within 12 hours 
in Schwann cells and immature, non-myelinating markers are upregulated. Within the 
first 2 weeks following nerve transection, Schwann cells divide. Both Schwann cells 
and macrophages have cleared most of the myelin debris after 3 weeks. The basal 
lamina  remains intact while the Schwann cell dedifferentiates and proliferates. 
Although extracellular matrix molecules such as laminin promote neurite 
outgrowth in vitro, regeneration is much better in the presence of Schwann cells. 
Schwann cells express in addition to other immature markers, cell adhesion molecules 
such as NCAM, L1, N-cadherin. Several in vitro experiments have shown that growth 
cones use L1 and N-cadherin to extend on Schwann cells and β integrins to grow 
on Schwann cell extracellular matrix (laminin) [1, 6]. In fact, myelin regeneration 
observed after WD, partly reproduces the steps of normal myelin development. 
Regeneration studies are useful to study both Schwann cell and neuronal contribution 
to myelination. 
Changes in other endoneurial cells
The endoneurial fibroblasts respond dramatically and proliferate similarly to Schwann 
cells within the first week. Each fibroblast surrounds partially a degenerating nerve 
fiber and weeks after axotomy fibroblasts may form a partial basal lamina, adopting 
a perineurial cell phenotype. In extreme cases, fibroblasts divide the nerve into mini-
fascicles. Furthermore, they appear to produce nerve growth factor, which provides 
an attractive environment for regeneration. Thus after transection, the process of 
Wallerian degeneration results in a favorable environment for invasion by regenerating 
sprouts. Additionally, the denervated Schwann cell, within the original Schwann cell 
basal lamina, provides a favorable pathway for regenerating axons. 
Through nerve grafting, a situation can be created, where a genetically 
distinct Schwann cell is introduced at the site of nerve transection. Since Schwann 
cells dedifferentiate and remain in their basal lamina, the grafted segment contains 
Schwann cells distinct from the host. Aguayo and colleagues have used grafting 
experiments to investigate the pathogenesis of trembler, quaking and dystrophic mice. 
For both trembler and quaking they identified a Schwann cell autonomous defect, 
while for dystrophic mice they found normal myelination in each experimental setting, 
implicating that the underlying defect in the dystrophic mouse was more complex 
[9]. 
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Four different experimental settings are required to interpret results of these grafting 
experiments. 
1. A baseline of regeneration in wildtype: engraft a wildtype nerve segment into 
a wildtype host
2. To have a baseline of regeneration in mutant mice: engraft a mutant nerve 
segment into a mutant host.
3. To study mutant Schwann cells: engraft a mutant nerve segment into a 
wildtype host 
4. To analyze mutant axons: engraft a wildtype nerve segment into a mutant 
host
Introduction to cloning experiments
How to find a gene
To find something you have to know what it is. Already in 1933 Demerec asked himself 
what is a gene? [10]. In his paper, published in Journal of Heredity, he writes that the 
obtained information about genes is indirect. Via analysis of inheritance, something 
could be said about obvious characters, their relative position to each other on a 
chromosome. He concludes that genes are organic molecules, either individually 
or in a complex they govern life processes of cells and thus of the organism [10]. 
Nowadays we can read in Molecular Biology of the Cell [11] that genes are regions of 
DNA that control a discrete hereditary characteristic, usually corresponding to a single 
protein or RNA. This definition includes coding and non-coding DNA sequences, 
encompassing the entire functional unit. Although much is changed, the principle 
idea remains the same. 
How to search for a gene?
Several strategies to link genotype and phenotype have been developed over the 
years. These strategies are generally referred to as forward genetics and reverse 
genetics.
1. Forward genetics; from phenotype to genotype. Genes causing a particular 
phenotype are identified using a positional cloning approach [12].
2. Reverse genetics; from genotype to phenotype. These strategies aim to 
assign function to a particular gene sequence through study of its primary 
sequence relationship with other genes, expression pattern and, most 
importantly, mutagenesis experiments [12].
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Positional cloning approach
Since ages humans create maps to define their position either on land, sea, or in the 
air. These efforts have resulted in the creation of topographical maps, sea guides, 
highway maps, etc. What about our genome? Are there landmarks in the genomic 
landscape to define our orientation throughout the desert of A, G, C, T’s?? [13] Our 
genome is mapped with different kinds of maps, including genetic, physical and 
transcript maps [14]. These maps could be generated thanks to either inheritance 
pattern, markers dispersed throughout nucleotides, restriction sites or expression 
profile. Each of them further defines the region of interest [13].
To summarize the strategy of positional cloning: genetic mapping (region on a 
chromosome where the disease gene is localised is defined by linkage and recombinant 
analysis), physical mapping (identification and isolation of genomic clones (e.g. YAC, 
P1, BAC or cosmid) that are located in the disease region, construction of contigs 
and assembly of a restriction map and transcript mapping (isolation of transcripts for 
candidate genes) [15]. 
A positional cloning strategy first defines a certain DNA segment in the genome, small 
enough to be directly sequenced completely to identify relevant mutations or to be 
used in complementation experiments to ultimately identify the gene or gene mutation 
underlying the phenotype of interest. 
Release of human genome databases
There are public and private databases. The private database from Craig Venter, 
named Celera genomics, used a shotgun sequencing approach together with the 
sequence data coming out of the public sequencing consortium (international human 
genome sequencing consortium or IHGS) to build a draft of the human genome 
sequence [16, 17]. Data from the worldwide public sequencing effort are accessible 
through the websites of NCBI, UCSC and Ensembl [18]. All these databases have 
their shortcomings and have to be treated with suspicion. The NCBI and UCSC 
database used the already available sequence data set as a starting point for a 
complete assembly using sequences from overlapping BAC clones. 
A large and growing number of genomes have been sequenced to date and 
made publicly available through the Ensembl, NCBI, UCSC and Celera databases. 
Most importantly these databases provide detailed annotations of the genome 
sequence with links to other databases containing information on gene structure, 
function, phenotypes and human diseases. Although the data of Celera and the 
others largely overlap some discrepancies between the datasets remain. Databases 
are far from perfect, but they are enormously helpful to select candidate genes 
between two non-recombinant markers. In addition, they enable comparison between 
species, giving an idea about the number of genes, their orientation, their intron-
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exon boundaries, protein information and which markers and clones cover the critical 
region of the genome. STS (anonymous markers), EST’s (expressed sequence tags) 
and Riken cDNA sequences, known genes, known proteins and predicted genes and 
proteins are shown [18]. The amount of information you get is overwhelming, making 
it difficult to select the relevant information.
Candidate genes
What are the characteristics of a candidate gene? In principle, any gene in a region 
defined by markers that segregate fully with the phenotype and are flanked by markers 
showing minimal recombination in a large set of meiotic chromosomes, should be 
considered a candidate gene. To select candidates for further study one needs to 
define a number of criteria. These criteria will of course depend to a large extent on 
the details of the phenotype. 
A first selection could be based on expression of the candidate genes. It 
is reasonable to discard candidate genes that are not expressed in the tissue of 
interest. However, this criterion should be approached with great care as cell non-
autonomous effects could play an important role in the phenotype. It is therefore 
important to establish the cell autonomy of the mutation, if possible (see chapter 3). 
Clearly a literature search is required to collect all the available data on the potential 
candidate genes. This data might give you an idea about the expression of the gene, 
about tissue specificity, about expression pattern in a certain differentiation stage in 
a particular celltype etc. Furthermore data of human patients or known phenotype 
in other species where a mutation is identified in this particular gene can be used to 
compare. The ultimate identification of the mutation underlying the phenotype will 
require genetic complementation (in case of recessive traits), creation of transgenic 
or cell culture models (dominant traits) or gene knock out models. 
If the mutation is in a suspected gene regulatory element other approaches 
such as bandshift and reporter gene expression studies might be performed. For 
example preaxial polydactyl is a disorder that is associated with a point mutation in a 
regulatory element 1 Mb away, resulting in ectopic Sonic hedgehog expression and 
as a consequence supernumerary preaxial digits [19]. 
Furthermore different mutations in the same gene can result in distinct 
phenotypes [20]. Recently this issue was studied in families with patients having either 
complex neurocristopathy or a more restricted phenotype known as Waardenburg-
Shah syndrome. Mutations in the Sox-10 gene (a transcription factor) have been 
found within those families. The severity of disease is associated with stability of 
mRNA. Unstable mRNAs are degraded by the non-sense mediated mRNA decay 
pathway, resulting in less severe phenotype. In contrast stable mRNA is translated 
into a mutant protein with a more severe phenotype [21].  
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Abstract
Mice homozygous for the autosomal recessive mutation claw paw (clp) are characterized by limb posture abnormalities and congenital
hypomyelination, with delayed onset of myelination of the peripheral nervous system but not the central nervous system. Although this
combination of limb and peripheral nerve abnormalities in clp/clp mice might suggest a common neurogenic origin of the syndrome, it is not
clear whether the clp gene acts primarily in the neurone, the Schwann cell or both. In the work described here, we address this question of cell
autonomy of the clp mutation through reciprocal nerve grafting experiments between wild-type and clp/clp animals. Our results demonstrate
that the clp mutation affects the Schwann cell compartment and possibly also the neuronal compartment. These data suggest that the clp gene
product is expressed in Schwann cells as well as neurones and is likely to be involved in direct axon–Schwann cell interactions. Within the
Schwann cell, clp affects a myelin-related signaling pathway that regulates periaxin and Krox-20 expression, but not Oct-6.
D 2004 Elsevier Inc. All rights reserved.
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Introduction
Congenital limb posture abnormalities in humans and
other vertebrates occur under a variety of circumstances and
clinically manifest as a singular abnormality or as part of a
syndrome. In clinical practice, such abnormalities are de-
scribed as arthrogryposis multiplex congenita (AMC;
arthron = ‘‘joint’’ and gryposis = ‘‘bent’’). It is generally
accepted that any condition resulting in reduced fetal
movement will lead to joint contractures in newborns
(Drachman, 1971; Hageman and Willemse, 1983; Hall,
1997). In principle, such conditions could be extrinsic or
intrinsic to the developing fetus. An example of the former
is provided by experiments in which chick or rat embryos
were paralyzed by injection with curare, causing limb
posture abnormalities at birth (Del Torto et al., 1983;
Drachman and Coulombre, 1962; Moessinger, 1983). Ad-
ditionally, maternal antibodies that functionally inhibit the
fetal acetylcholine receptor cause arthrogryposis in human
fetuses (Jacobson et al., 1999; Matthews et al., 2002; Polizzi
et al., 2000).
Intrinsic causes of reduced fetal movement can be classi-
fied as either myogenic and/or neurogenic in origin. In
several clinical cases, AMC was found associated with
congenital hypomyelination of the peripheral nerves suggest-
ing a common aetiology (Boylan et al., 1992; Charnas et al.,
1988; Seitz et al., 1986). In the peripheral nervous system,
myelin formation and maintenance of the peripheral nervous
system by Schwann cells is dependent on continuous recip-
rocal interactions between the axon and Schwann cell (Fields
and Stevens-Graham, 2002). Mutations that affect this dia-
logue by disabling function in the Schwann cell, the axon or
in both result in dys- or demyelinating neuropathies as in the
human hereditary motor and sensory neuropathies (Suter and
Scherer, 2003). Limb posture abnormalities, mostly pes
cavus, and distal muscle wasting frequently develop in these
patients as consequence of axonal loss.
Congenital limb posture abnormalities are observed in
mice homozygous for the murine autosomal recessive
mutation claw paw (clp) (Henry et al., 1991). In affected
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animals, the forelimbs are flexed at one or more of the joints
(shoulder, wrist or digital joints) but extended at the elbow,
resulting in the forelimbs pointing in the direction of the
hindlimbs. These abnormalities are visible within 2 days of
birth. More severely affected animals also show involve-
ment of one or both hindlimbs. Pathological examination of
affected animals demonstrates severe congenital hypomye-
lination with delayed onset of myelination of the peripheral
nerves with central nerves unaffected. Persistently blocked
myelination is observed in a fraction of the smaller axons
(Henry et al., 1991). Additionally, it was found that the
mean internodal length is greatly reduced for all axonal size
classes in clp/clp nerves when compared to heterozygous or
wild-type animals (Koszowski et al., 1998). The clp gene
has not been identified yet, although mapping studies have
placed the gene close to the Gpi locus on mouse chromo-
some 7 (Henry et al., 1991). No mutations were found in the
myelin-associated glycoprotein (MAG) gene, close to the
Gpi locus, excluding this gene as a clp candidate (Niemann
et al., 1998). The pathology of the clp/clp mouse is
strikingly similar to the clinically described cases of AMC
mentioned above. Hence, clp/clp mice provide an opportu-
nity to study the basis of the relationship between arthrog-
ryposis and hypomyelination.
It has been hypothesized that the clp gene is part of the
neurone–glia signaling system that governs myelination
initiation during development. However, it is not known
what cellular and molecular components of this signaling
system are affected by the clp mutation. To further charac-
terize this mutant mouse, we set out to determine whether
the gene acts in the neurone, the Schwann cell or both,
through reciprocal nerve graft experiments. Additionally, we
studied the interaction of the clp gene with many known
Schwann cell autonomous regulatory genes involved in
myelination including the transcription factors Oct-6 and
Krox-20 (Topilko and Meijer, 2001). Our results indicate
that clp function is required within the Schwann cell as well
as in the neurone. Upregulation of the promyelin transcrip-
tion factor Oct-6 is not affected by clp, while the subsequent
Krox-20 activation is delayed. Additionally, embryonic
periaxin expression is absent or reduced in clp/clp Schwann
cells and postnatal expression is delayed. Taken together,
these results suggest that clp is involved in neurone–glia
interactions and furthermore that, within the Schwann cell,
clp is involved in a pathway that regulates periaxin and
Krox-20 expression. This clp-dependent pathway is parallel
and non-redundant to the myelin-related Oct-6-dependent
pathway.
Materials and methods
Animal surgery
Nerve crush experiments were performed on young adult
F2 animals from a C57BL6J/Balbc-clp heterozygous inter-
cross. Affected and non-affected mice were anesthetized by
inhalation of halothane and placed on a heating pad. The left
sciatic nerve was exposed and crushed for two times 15 s at
mid-femoral level using No.5 Biology forceps. Mice were
sacrificed 4 weeks after the operation through trans-cardiac
perfusion with a solution of 1% gluteraldehyde/3% parafor-
maldehyde in 100 mM cacodylate (pH 7.4). The operated
and contralateral nerve was isolated for light and electron
microscopic analysis.
Transplantation experiment
Reciprocal nerve grafting experiments were performed
between wild type and wild type (wt:wt), wild type and
clp/clp (wt:clp), clp/clp and wild type (clp:wt) and between
clp/clp and clp/clp (clp:clp). All animals were of C57BL6J
background, obviating the use of immune-suppressants to
prevent graft rejection. Operations were performed on two
animals at a time, both animals serving as nerve donor and
recipient. Two mice of appropriate genotype were anesthe-
tized through inhalation of halothane and placed on a
heating pad. The left sciatic nerve was exposed in both
animals. Approximately 7.5 –10 mm of nerve was excised
and placed in the same orientation in the host animal. Nerve
and muscle tissue were kept wet by regular application of a
drop of sterile phosphate-buffered saline (PBS). The nerves
were sutured at both the proximal and distal anastomosis site
with two 10-0 black filament sutures. The retracted muscles
were placed back in position and the skin was sutured. All
surgical manipulations were done under a microscope.
Animals were transferred to a clean cage and allowed to
recover under a heating lamp. Animals were carefully
monitored for wound healing on a daily basis. Four weeks
after transplantation, animals were sacrificed.
Perineurium permeability
A 1% Evans Blue (Sigma) solution in 5% bovine serum
albumin (fraction V)/PBS (pH 7.4) was dialyzed overnight
in PBS. The sciatic nerves of an adult claw paw animal and
a wild-type littermate were dissected out and placed imme-
diately in 4 ml of Evans blue albumin (EBA) solution at
room temperature. After a 30- or 60-min incubation period,
nerves were briefly washed in PBS and fixed in 4%
paraformaldehyde for 2 h. Nerves were cryoprotected in
30% sucrose/PBS, frozen and sectioned at 24 Am. Sections
were mounted in VectashieldR (Vector laboratories) and
viewed immediately under a fluorescence microscope.
Quantitative RT-PCR
Total RNAwas extracted from sciatic nerves using RNA-
Bee (Tel Test Inc.). First-strand cDNA was generated using
Superscript II (Invitrogen) reverse transcriptase and oligo-
dT as primer. The following primers were used to amplify
dhh and cyclophilin transcripts: dhh forward, CATGTGGC-
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CCGGAGTACGCC; dhh reverse, CGCTGCATCAGCG-
GCCAGTA; cyclophilin forward, GGTCAACCCCAC-
CGTGTTCTTCGACAT; cyclophilin reverse, GGACAA-
GATGCCAGGACCTGTATGCT. Annealing temperature
for dhh primers: 60jC, annealing temperature for cyclo-
philin primers 68jC. Aliquots were taken from the reaction
with two cycle intervals and amplification products were
analyzed on a 1.8% agarose gel.
Light/electron microscopy
Anesthetized animals were sacrificed through transcar-
dial perfusion with PBS (pH 7.4) for 3 min followed by
fixative [3% PFA (Sigma); 1% glutaraldehyde (Sigma) in
100 mM cacodylate buffer, pH 7.2] for 10 min. Sciatic
nerves were isolated, fixed overnight in the same fixative at
4jC. The next day, nerves were rinsed with 0.2 M cacody-
late buffer, osmicated in 1% osmium tetroxide solution and
embedded in Epon. Sections (1 Am) of Epon-embedded
sciatic nerves were mounted on glass slides and stained with
methylene blue. Ultra-thin cross sections from nerve grafts
at mid-graft level were cut and uranyl acetate and lead
citrate stained for electron microscopic analysis (Philips
CM100).
Nerve conduction velocities
Nerve conduction velocities were measured on the tail
nerve of anesthetized animals. Animals were placed on a
thermo-comfort heating pad at 38jC. Recording and stim-
ulation electrodes were made of 300-Am tungsten needles
with a 10-Am tip. The stimulus frequency and stimulation
period was 1 Hz and 0.1 ms, respectively. Impedance of the
recording electrode was 100 and 25 kV/kHz for the stim-
ulation electrode.
Immunohistochemistry
Rabbit polyclonal antibodies used in this study are direct-
ed against Oct-6 (Jaegle et al., 2003), Periaxin (Scherer et al.,
1995) andKrox-20 (1:400). The Krox-20 antibodywas raised
against the unique amino-terminal portion of the protein
(amino acids 1–180). Animals were immunized with
6xHis-tagged Krox-201–180 protein expressed in E. coli
(M15 strain) and purified on Ni2+-NTA-agarose beads (QIA-
GEN). Mouse monoclonal antibodies used were against P-
zero (1:1000) (Archelos et al., 1993) and neurofilament
medium chain (1:200, hybridoma 2H3, Developmental Stud-
ies Hybridoma Bank).
Embryos and tissues were isolated, fixed in a mixture of
methanol, acetone, acetic acid and water (35:35:5:25) for 1
h at 4jC, embedded in paraffin and sectioned at 7 Am. After
dewaxing, tissue sections were hydrated and blocked in 1%
BSA, 0.05% Tween-20 in PBS. Rabbit antibodies and
mouse monoclonal antibodies were incubated simultaneous-
ly in PBS/0.05% Tween-20 overnight at room temperature.
Oregon Green-conjugated goat anti-rabbit IgGs (Molecular
Probes) and Texas Red-conjugated goat anti-mouse IgGs
(Molecular Probes) were subsequently used as secondary
antibodies. The tissue was viewed using a Leica fluores-
cence microscope.
Results
Morphological examination of clp nerves and comparison
with Oct-6 mutant nerves
Our interest in the clp mouse mutant was initially raised
by the similarities in peripheral nerve phenotypes between
claw paw mice and Oct-6 transcription factor mutant mice
(Bermingham et al., 1996; Henry et al., 1991; Jaegle et al.,
1996). Both mice are characterized by delayed initiation of
myelination of their peripheral nerves. The similarities
between these phenotypes suggested several possible inter-
actions between the Oct-6 and clp genes. For example, it is
possible that the clp gene product is involved in those
signaling pathways that activate Oct-6 or, clp could be a
major regulatory target of Oct-6. Alternatively, clp could act
in a non-redundant pathway parallel to Oct-6. To begin to
answer these questions, we first compared nerve morpho-
logy in both mutant and wild-type mice at several postnatal
stages of development. Previously, nerve morphology in
clp/clp animals has been described only from postnatal day
14 (P14) onwards (Henry et al., 1991). Therefore, we
extended this analysis to include earlier stages of nerve
development. Fig. 1 shows a comparison of representative
transverse sections through the sciatic nerve of animals of
different genetic background at different stages of postnatal
development.
The sorting of prospectively myelinated axonal fibers by
Schwann cells during late fetal development culminates in
the promyelin stage of cell differentiation in which a
Schwann cell has established a one to one relationship with
its axon. These cells will exit the cell cycle, elaborate a basal
lamina and initiate myelination. The majority of myelin-
competent cells transit through this stage during the first
week of postnatal life. This is evident in transverse section
of the wild-type sciatic nerve at birth, in which many
promyelin cells can be observed with some cells already
actively myelinating (Fig. 1A, panel a). By P8, a majority of
cells is actively myelinating and at P16 almost all myelin-
competent cells are in an advanced stage of myelination
(Fig. 1A, panels d and g). In contrast to wild-type, clp/clp
Schwann cells are still at a very immature sorting stage at
birth (Fig. 1, panel b). Most Schwann cells are found at the
periphery of naked axon bundles, with cellular extensions
pioneering into the bundles. This configuration of Schwann
cells and naked axon bundles is typically observed in
embryonic nerves around mouse embryonic day 17 (E17)
(Feltri et al., 2002). To illustrate this developmental stage of
clp/clp Schwann cells more graphically, we traced the
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outline of several cells in a P1 nerve highlighting the
cytoplasmic extensions of the sorting Schwann cell (Fig.
1B). One week later, these axon bundles are sorted out and a
majority of Schwann cells have acquired a promyelin
configuration (Fig. 1, panel e). Over the next week, many
promyelin cells initiate myelination, such that by P16, a
large number of myelin figures are observed. However, a
substantial number of Schwann cells are still at the promye-
lin stage of cell differentiation, suggesting that this transition
occurs at a lower rate in clp/clp Schwann cells than in wild-
type Schwann cells (Fig. 1, panel h). By P32, the majority of
clp/clp Schwann cells are actively meylinating with only
few cells remaining in the promyelin configuration (data not
shown and Henry et al., 1991). In contrast to clp/clp
Schwann cells, Oct-6 mutant Schwann cells transit through
the sorting stage of development normally, but then stall at
the promyelin stage for several days before initiating myeli-
nation (Fig. 1A, panels c, f and i). Thus, clp/clp Schwann
cells appear strongly inhibited in the sorting stage of nerve
development and to a lesser extent in the promyelinating to
myelinating transition.
One other remarkable difference between clp/clp nerves
and Oct-6 mutant nerves (and wild-type nerves) is the
extensive fasciculation of the former. Division of the endo-
neurium by flattened, perineurial-like cells is already appar-
ent at P8 in clp/clp nerves (Fig. 1A, panel e). As illustrated
in Fig. 2A, these cells contain, like perineurial sheath cells,
many caveolae and secrete a basal lamina (arrows and
arrowheads, respectively, in Fig. 2A, panel a). The number
of cell layers that make up the perineurium and the mor-
phology of the perineurial cells appear normal in clp/clp
nerves at P16 and adult (Fig. 2A, panel b, and data not
shown). The hyper-fasciculation phenotype observed in clp/
clp peripheral nerves is reminiscent of that observed in dhh
mutant animals (Parmantier et al., 1999). Therefore, it is
possible that this particular aspect of the claw paw pheno-
type results from a failure to express dhh in the developing
nerve. We therefore examined expression of dhh mRNA in
clp/clp and wild-type nerves at P12 using quantitative PCR
normalized to cyclophilin expression. We found that dhh is
expressed in P12 clp/clp nerves, albeit at reduced levels
(Fig. 2B). It is therefore possible that the extensive subdi-
vision of clp/clp nerves by perineurial sheath cells is a
consequence of reduced dhh expression. It has been hy-
pothesized that the hyperfasciculation of dhh mutant nerves
results from a functionally defective perineurium (Parmant-
ier et al., 1999). A major function of the perineurium is to
prevent the invasion of cells and macromolecules from the
surrounding tissue into the endoneurium (Thomas et al.,
1993). This nerve–tissue barrier function of the perineurium
is compromised in dhh mutant animals as evidenced by the
penetration of dye loaded serum albumin into the endoneu-
Fig. 1. Abnormal development of peripheral nerves in clp/clp and Oct-6 mutant mice. (A) Shown are representative micrographs of transverse sections of
sciatic nerves from wild-type, clp/clp (claw paw) and Oct-6 mutant (Oct-6hgeo/hgeo) animals at P1 (a, b and c), P8 (d, e and f ) and P16 (g, h and i). At P1,
axonal sorting is well advanced in wild-type nerves, with many axons in a 1:1 relationship with Schwann cells and few in an early myelinating stage (a). In
contrast, axonal sorting in clp/clp nerves is in a very early stage with large groups of unsorted axons (b). Sorting in Oct-6 mutant nerves is well advanced with
most cells in a late sorting and promyelin stage (c). At P8, the majority of myelin-competent Schwann cells in wild-type nerves are actively engaged in
myelination (d), while in clp/clp nerves Schwann cells have now adopted a promyelin configuration (e). At this time, most Oct-6 mutant Schwann cells are
still at the promyelin stage of differentiation (f ). At P16, myelination is well advanced in wild-type nerves (g). In contrast, only a fraction of clp/clp, and Oct-6
mutant, Schwann cells have progressed to the myelinating stage of differentiation with many cells still at the promyelin stage (h and i). Scale bar: (a–c) 1.6
Am; (d– f ) 2.8 Am; (g– i) 5 Am. (B) Axonal sorting is delayed in nerves of clp/clp (claw paw) mice. In this representative micrograph, clp/clp Schwann cells
are just beginning to send out processes in the axon bundles. The outline of sorting Schwann cells is traced with a colored pencil. Each color represents an
individual Schwann cell. Scale bar: 2 Am.
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rium (Parmantier et al., 1999). We similarly tested the
integrity of the tissue–nerve barrier in claw paw nerves.
After 1 h exposure to a Evans blue albumin solution ex
vivo, nerves were processed for fluorescence microscopy.
No dye complex had penetrated the endoneurium of wild-
type or claw paw nerves (Fig. 2C, panels a and b, respec-
tively) demonstrating that, in contrast with dhh mutant
nerves, the nerve–tissue barrier in claw paw mice is intact.
Thus, clp/clp nerves resemble dhh mutant nerves in their
extensive subdivision into smaller fascicles by perineurial
sheath cells but have, unlike dhh mutant nerves, a function-
ally intact perineurium.
Activation of Oct-6 expression in clp/clp nerves
As previous work has demonstrated that the transcription
factors Oct-6 and Krox20 are major cell-autonomous regu-
lators of the Schwann cell myelination program, it is
possible that the delayed myelination phenotype in clp/clp
nerves can in part be explained by a failure to activate Oct-6
and subsequently Krox-20, in clp/clp animals (Ghislain et
al., 2002). We therefore examined expression of Oct-6,
Krox-20 and the myelin proteins P-zero and periaxin in
clp/clp animals at P8 and P16 by immunohistochemistry and
compared it with the expression of these proteins in wild-
type and Oct-6 mutant Schwann cells (Fig. 3). At P8, most
clp/clp Schwann cells are, like most Oct-6 mutant cells, at
the promyelin stage of cell differentiation (see Fig. 1) and
will commence myelination in the course of the next 2
weeks. As shown in Fig. 3A, Oct-6 is expressed in Schwann
cells of clp/clp animals at P8. This is in agreement with
previous mRNA expression data (Bermingham et al., 2002).
As reported earlier, Oct-6 is an upstream regulator of Krox-
20 and hence, Oct-6 mutant Schwann cells do not express
Krox-20 (Ghazvini et al., 2002; Ghislain et al., 2002).
Despite the expression of Oct-6 in clp/clp Schwann cells,
Krox-20 is not expressed at P8, but eventually is activated in
clp/clp nerves (and Oct-6 mutant nerves) when myelination
proceeds (Ghazvini et al., 2002 and Fig. 3B, panel a). As
expected, P-zero expression is very low in both mutant
mouse strains at P8, as the majority of Schwann cells have
not yet produced compact myelin (Fig. 3A, panels h and i).
However, at P16, clp/clp nerves show strong P-zero immu-
noreactivity in myelin-forming Schwann cells (Fig. 3B,
panel b). Interestingly, the myelin protein periaxin appears
reduced or misexpressed in clp/clp Schwann cells at P8.
This is in contrast to promyelin-arrested Oct-6 mutant
Schwann cells in which periaxin is expressed at near normal
levels (panels j, k and j). However, once clp/clp cells form
compact myelin, high levels of periaxin are observed in
these cells (Fig. 3B, panel c). Thus, in contrast to Oct-6
mutant Schwann cells, periaxin protein does not accumulate
in promyelin-arrested clp/clp Schwann cells suggesting that
the clp mutation affects activation of periaxin expression or
subcellular localization and/or processing.
To distinguish between these possibilities, we further
examined periaxin expression at late fetal stages of deve-
lopment in clp/clp and wild-type animals. Periaxin is first
expressed in the nuclei of embryonic Schwann cells at E14.
By E17, periaxin expression shifts to the cell membrane and
by E18, periaxin is no longer found in the nucleus (Sherman
and Brophy, 2000). We examined periaxin expression in
clp/clp Schwann cells of embryonic nerves at E17, the stage
at which claw paw animals can first be recognized. No
periaxin is detected in clp/clp nerves at this stage (Fig. 4A,
panel d). In contrast, wild-type Schwann cells express
periaxin in the nucleus and/or in the cytoplasm (Fig. 4A,
panel c). Thus, the clp mutation affects onset of periaxin
expression at this embryonic stage and subsequently, also
the subcellular localization of the periaxin protein.
Fig. 2. Morphological and functional characterization of the perineurium of claw paw nerves. (A) Perineurial-like cells subdivide the endoneurium of claw paw
nerves (panel a). This electron micrograph shows the typical flattened extensions of perineurial-like cells studded with numerous caveolae (arrows) and the
basal lamina produced by these cells (arrowheads). Schwann cells (Sc) and the nucleus of a perineurial cell (P) are indicated. The number of cellular layers and
the morphology of the perineurial cells appear normal in the developing perineurium of claw paw nerves (panel b). The epineurium is poorly defined at this
stage and later stages. Scale bar: 500 nm. (B) dhh mRNA expression is reduced in claw paw nerves. Expression levels of dhh were estimated using quantitative
RT-PCR during the exponential phase of the reaction and normalized against cyclophilin (cyclo), a housekeeping gene expressed at rather constant levels.
Samples were taken with two-cycle intervals. It is estimated that dhh mRNA levels are 4- to 16-fold lower in claw paw nerves at P12. (C) The nerve– tissue
barrier function of the perineurium is intact in claw paw nerves. Following submersion of dissected sciatic nerve of wild-type (panel a) or claw paw nerve
(panel b) for 1 h in EBA solution, EBA is found associated with the epi- and perineurial sheath of the nerve (arrows). EBA did not penetrate the endoneurium
of wild-type or claw paw nerves (asterisk). However, strong EBA staining is seen within muscle tissue lying next to the nerve (arrowhead).
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We next examined whether Oct-6 is also delayed in its
onset of expression. Oct-6 protein normally starts to accu-
mulate in the nuclei of immature Schwann cells of the
sciatic nerve at late fetal stages and reaches maximum levels
in promyelin cells during the first postnatal week of deve-
lopment. As clp/clp Schwann cells at P1 morphologically
resemble Schwann cells in E16–E17 wild-type embryonic
nerves, we examined Oct-6 expression in P1 clp/clp nerves.
At this stage, we found that clp/clp Schwann cells already
express appreciable levels of Oct-6 (Fig. 4B, panel b),
demonstrating that the clp gene product does not affect
activation of Oct-6 expression. In contrast to wild-type Oct-
6-positive Schwann cells, Oct-6-positive clp/clp Schwann
cells do not express appreciable levels of P-zero protein
(Fig. 4B, panels c and d).
Taken together, these data demonstrate that the clp
mutation affects nerve maturation through a pathway that
includes activation of periaxin, but not Oct-6, and thus
strongly suggest that during Schwann cell differentiation,
periaxin and Oct-6 are regulated through distinct signaling
pathways.
Nerve conduction velocities of clp nerves are reduced
The delayed maturation of peripheral nerves in clp/clp
animals results in reduced internodal lengths for all diameter
classes and thus, in the absence of axonal loss, increased
Schwann cell numbers. In addition, myelin thickness is
reduced in some, but not all, clp/clp animals and no decrease
in mean axon diameter was reported (Henry et al., 1991;
Fig. 3. Developmental expression of Oct-6, Krox-20, P-zero and periaxin in clp/clp and Oct-6mutant nerves. (A) Transverse sections of sciatic nerves of clp/clp
(claw paw), Oct-6 mutant (Oct-6DSCE/DSCE) and control (wild-type) mice at P8 were stained for Oct-6 (a–c), Krox-20 (d–e), P-zero (g– i) and periaxin (j – l). In
the control nerve, myelinating Schwann cells express Oct-6, Krox-20 and the myelin proteins P-zero and periaxin (a, d, g and j). At P8, most clp/clp Schwann
cells have adopted a promyelin configuration and express Oct-6 (b) but not the myelination-associated transcription factor Krox-20 (f ). Some cells express
appreciable levels of P-zero. These cells are probably in an advanced promyelin stage as there is no evidence of compact myelin yet at this stage (h). Very low
cytoplasmic periaxin expression is observed in many, but not all, cells (k). Few cells exhibit high level of periaxin expression. No nuclear periaxin staining is
observed at this stage. Like clp/clp Schwann cells, Oct-6 mutant Schwann cells do not express Oct-6 or Krox-20 at this stage (c and e). The few cells that have
initiated myelin formation are strongly positive for P-zero (i). In strong contrast to clp/clp Schwann cells (k), Oct-6 mutant cells express already high levels of
periaxin at this stage (l). Magnification �40. (B) Myelin formation is evident in clp/clp nerves at P16. An appreciable number of Schwann cells have initiated
myelination and express Krox-20 (a). High levels of P-zero and periaxin are present in Schwann cells that have formed compact myelin (b and c).
Magnification �40.
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Koszowski et al., 1998). The mean internodal length in
every axonal diameter class in clp/clp animals is approxi-
mately half of that of wild-type animals. Intuitively, and on
theoretical considerations, it is to be expected that propaga-
tion of action potentials will be slowed when the mean
internodal length drops well below its optimum (Brill et al.,
1977; Goldman and Albus, 1968; Rushton, 1951). To assess
nerve conduction velocity (NCV) in clp and wild-type
animals, we measured compound action potentials (CAP)
of the tail nerve (Fig. 5A). The mean NCV in wild-type and
heterozygous mice was 35.3 m/s (SD 1.8). In contrast, the
mean NCV in clp/clp mice was 23.9 m/s (SD 2.2), a
reduction of 35% (Fig. 5B). A similarly reduced conduction
velocity was observed for motor nerves within the sciatic
nerve of clp/clp animals as compared to wild type (data not
shown). Reduced NCV in the tail nerve of claw paw mice
shows little variance, and this variance does not correlate
with age or severity of the behavioral phenotype. Thus, it is
possible that the reduction in NCV in clp/clp animals can be
accounted for, at least in part, by the reduction in mean
internodal length.
Response to nerve injury
Although the claw paw phenotype has been described as
a developmental abnormality, it is not clear from these
observations whether the phenotype results from an intrinsic
defect in one or more components of the developing nerve
or through defects in other organs of the developing fetus.
Studying the damage response of the nerve in the adult
animal allows examination of Schwann cell–axon interac-
Fig. 5. Nerve conduction velocities are reduced in clp/clp nerves. (A)
Representative recordings of compound action potentials of the tail nerve of
wild-type (wt) and clp/clp (claw paw) animals. Arrows indicate the
stimulation artefact. (B) Mean conduction velocity for wild-type (wt) and
clp/clp (claw paw) nerves. The number (n) of animals from which
recordings were obtained in each group is indicated. The error bar
represents standard deviation. The difference in mean NCV between clp/clp
and wild-type animals is significant (P < 0.00001, Student’s t test).
Fig. 4. Expression of periaxin and Oct-6 in clp/clp Schwann cells. (A) Embryonic sciatic nerve is visualized by expression of the neurofilament medium chain
in the axonal fibers (Nfm; a and b). Embryonic Schwann cells within the nerve express periaxin in their cytoplasm or nucleus (c). In contrast, no periaxin
expression is observed in nerves of claw paw embryos at this stage of development (d). (B) Oct-6 is expressed in all Schwann cells in newborn wild-type sciatic
nerves (a). Also, Schwann cells in sciatic nerves of clp/clp animals express Oct-6 (b). Other than wild-type Schwann cells, clp/clp Schwann cells uniformly
express high levels of Oct-6. In wild-type nerves, many Schwann cells are at the promyelin configuration and some have initiated myelination and thus express
high levels of P-zero (c). In contrast, clp/clp Schwann cells appear at an early sorting stage at P1 (see Fig. 1) and do not express detectable levels of P-zero
protein (d).
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tions that are largely a reiteration of developmental events
(Scherer and Salzer, 1996). Following nerve transection,
axons and myelin in the distal nerve segment disintegrate in
a process called Wallerian degeneration. Schwann cells
revert back to an immature pre-myelinating phenotype,
proliferate and participate with macrophages in the removal
of myelin and axonal debris. These reactive Schwann cells
create an environment that stimulates axonal regeneration of
the transected neurones. Upon restoration of axonal contact,
Schwann cells differentiate into myelin or non-myelin
forming cells (Scherer and Salzer, 1996). Therefore, if the
clp defect resides within the nerve tissue, it is likely that at
least part of the defect will be recapitulated during nerve
regeneration following nerve axotomy in an adult animal.
On the other hand, if the clp defect is strictly developmental
and not intrinsic to the nerve tissue, it is expected that
regeneration will be relatively normal.
To examine the effect of the clp mutation on Schwann
cell–axon interaction during regeneration, the sciatic nerve
of adult clp/clp and wild-type mice were crushed and
studied morphologically 4 weeks later (Fig. 6). The nerves
were sectioned at two levels distal to the injury, 3 and 6 mm,
respectively, representing two successive stages of regener-
ation. In wild-type animals, regeneration is well advanced,
with only few remnants of myelin remaining (arrows in Fig.
6A, panel b) and most axons associated with compact
myelin. Regeneration of clp/clp nerves differs significantly
from wild-type nerves in some aspects. First, most large-
caliber axons are ensheathed by a single Schwann cell, but
only a few of these are associated with a thin compact
myelin sheath (Fig. 6A, panels e and f). Second, supernu-
merary Schwann cells surround large axon–Schwann cell
units and are associated with numerous thin axons (Fig. 6B).
These structures are enclosed by the original basal lamina
(arrows in Fig. 6B), indicating excessive sprouting of the
regenerating axon. Third, excessive fasciculation results in a
further subdivision of the clp nerve (Fig. 6A, panels e and f).
Thus, while clp axons do grow back into the distal nerve
stump, regeneration is clearly disturbed. Some of these
regeneration abnormalities, such as delayed myelination
and hyper-fasciculation, are also observed during develop-
ment suggesting that the clp defects are caused by a nerve
intrinsic defect in one or more components within the
developing or regenerating nerve.
Nerve grafting
To distinguish between a Schwann cell and neuronal
defect in the regeneration of clp/clp nerves, we performed
nerve grafting experiments. Nerve transplantation experi-
ments create a situation in which Schwann cells, genetically
distinct from the host, differentiate in association with host-
derived neurons (Aguayo et al., 1977; de Waegh and Brady,
1991; Scaravilli and Jacobs, 1981). We performed nerve
transplantation operations in which a wild-type host was
engrafted with a segment of a wild-type (wt:wt) or clp/clp
(clp:wt) sciatic nerve segment. Also, the converse set of
transplantations was performed in which a clp/clp host was
engrafted with a wild-type (wt:clp) or clp/clp (clp:clp)
sciatic nerve segment. The poorly developed epineurium
of clp/clp nerves as compared to that of wild-type nerves
made the grafting of the segments particularly demanding
on the technical level. Four weeks after the operation, the
transplanted nerves were isolated and examined microscop-
ically. Each nerve was serially sectioned and examined at
250-Am intervals. Representative sections from the middle
of the graft and proximal and distal to the anastomosis site
are shown in Fig. 7. In the wt:wt transplantation, regenerat-
Fig. 6. Abnormal response to nerve injury in clp/clp mice. (A) Light micrographs of cross sections of sciatic nerves of young adult wild-type and clp/clp (claw
paw) animals 4 weeks after nerve crush. The myelin sheath in clp/clp nerves is thinner than in wild-type nerves, as described earlier (a and d). In wild-type
nerves, regeneration is well advanced, both at 3 and 6 mm distal of the nerve crush (b and c), with only little myelin debris remaining (arrows in panel b). All
regenerated axons are myelinated. Regeneration in clp/clp nerves is delayed with only few regenerated axons myelinated. This is even more pronounced at 6
mm distal to the lesion, corresponding to a later time point in regeneration (f ). Excessive fasciculation is evident in the regenerating nerve. A layer of epineural
cells enclosing a group of regenerating fibers is indicated with arrows (e). Scale bar: 10 Am. (B) In this electron micrograph of a regenerating clp/clp nerve,
supernumerary Schwann cells are associated with regenerating axons. In addition to the large central axon, excessive numbers of axon sprouts (red asterisks)
are observed within the regenerating unit that is enclosed by one basal lamina (arrows). The cross section is through three Schwann cells. Scale bar: 2 Am.
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ing axons have grown through the graft and entered the
distal nerve stump. Wild-type Schwann cells in the graft and
distal nerve stump have formed compact myelin around
regenerated axons (Fig. 7, panels b and c). Schwann cell
tubes (reactive Schwann cells within their basal lamina:
bands of Bunger) that were not re-innervated still contain
some myelin debris (arrows in panel b). In the clp:wt
transplantation, wild-type axons do regenerate through a
clp/clp nerve graft into the distal nerve stump (Fig. 7, panels
e and f ). Moreover, in contrast to wild-type Schwann cells,
clp/clp Schwann cells have only myelinated the larger axons
in the graft and many axons are still in an early ensheathing
Fig. 7. Nerve grafting experiments reveal Schwann cell and neuronal expression of the clp defect. Light micrographs of semi-thin cross sections of sciatic nerve
at three different levels of the engrafted nerve 4 weeks after the operation. The position of the sections relative to the engrafted segment is schematically
depicted in the diagram above the micrographs. At the level of the engrafted segment and distal to this segment, three different configurations are expected:
regenerated axons myelinated by graft-derived Schwann cells (blue in diagram); Schwann cell tubes (blue) that do not get re-innervated by host neurones and
host axons that do not enter the nerve graft and are associated with host-derived Schwann cells (gray in diagram) that migrate with the regenerating axons.
Donor and recipient genotypes (donor/recipient) are listed to the left. Non-innervated Schwann cell tubes with myelin debris are indicated with arrows in panel
b. Thinly myelinated axons that have re-innervated the distal nerve segment of the wild-type host are indicated in panel f with arrows. Arrows in panel h also
point to regenerating wild-type axons that are myelinated by clp/clp Schwann cells. For further details, see text. Scale bar: 10 Am.
A. Darbas et al. / Developmental Biology 272 (2004) 470–482478
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or promyelin configuration (panel e). Smaller axons that
have navigated through the graft and have entered the distal
nerve stump are normally myelinated (arrows in panel f ).
These observations suggest that at least part of the delayed
myelination phenotype in clp/clp animals is Schwann cell
autonomous.
Transplantations of wild-type nerve segments into clp/
clp hosts were less successful as ligations to the distal
nerve stump did not hold. Nevertheless, clp/clp axons did
enter the wild-type nerve graft and were myelinated by the
wild-type Schwann cells within the graft (Fig. 7, panel h).
Also smaller-caliber claw paw axons were myelinated
(arrows in panel h). Distal to the second anastomosis site,
regrowing axons did not enter the distal nerve stump, but
were found associated with a large blood vessel (not
shown). Most likely, graft-derived perineural cells and
Schwann cells accompany these axons (panel i). Notwith-
standing, these data suggest that wild-type Schwann cells
receive appropriate signals from clp/clp neurones to mye-
linate them. Finally, the clp:clp transplantations show that
clp/clp axons do grow through the grafted segment into the
distal nerve stump. Consistent with the results in the clp/clp
nerve crush experiment (Fig. 6), regenerating clp/clp axons
are associated with supernumerary Schwann cells and only
few axons are thinly myelinated (Fig. 7, panels k and l).
We also observe a further increase in the extent of
fasciculation. This increased fasciculation was less pro-
nounced in the clp:wt and in wt:clp transplantations.
Therefore, this specific aspect of the claw paw phenotype
arises mainly from interaction of clp/clp axons with the clp/
clp endoneurium. This is also true for the delayed myeli-
nation phenotype, as it is much more severe in the clp:clp
transplantation than in the clp:wt and wt:clp transplanta-
tions. Thus, while the former two grafting experiments
(wt:clp and clp:wt) suggest a Schwann cell autonomous
effect of the clp mutation on myelination, the nerve crush
and clp:clp transplantation suggest that there is also an
important Schwann cell non-autonomous, most likely neu-
ronal, aspect to the clp mutation.
Discussion
We have studied the cellular and molecular basis of the
congenital limb abnormality manifested by claw paw mutant
mice. Our findings demonstrate that the clp mutation affects
both the axonal and endoneural/Schwann cell compartment,
resulting in axonal sorting and myelination defects. At the
molecular level, clp affects a signaling pathway that is
parallel and non-redundant to the Oct-6-dependent pathway,
suggesting that axonal signals that drive Schwann cell
differentiation and myelination are transduced through mul-
tiple parallel pathways. These findings suggest several
possible roles for the clp gene and, additionally, define a
set of requirements for clp candidate genes, to be identified
in the ongoing positional cloning effort.
What process in nerve development is affected by the clp
mutation?
The development of peripheral nerve tissue can be
conveniently thought of as an ordered series of cellular
transitions that result from several complex interactions
between Schwann cells, axons, mesenchymal cells and
extracellular components (Jessen and Mirsky, 1999; Web-
ster, 1993). The first transition occurs when migrating neural
crest cells associate with outgrowing axon bundles and
acquire Schwann cell precursor characteristics (Jessen and
Mirsky, 1991; Jessen et al., 1994). These cells proliferate,
migrate with the growing axons and, in a second transition,
differentiate into immature Schwann cells that invade the
axon bundles and start the process of radial sorting of nerve
fibers. This process culminates in larger axons singled out
by individual Schwann cells (promyelin stage) which, in a
third transition, will go on to myelinate their axon and
multiple smaller axons associated with Schwann cells to
form the so-called Remak fibers of non-myelinated axons.
During this last phase, immature Schwann cells exit the cell
cycle and elaborate an extracellular matrix. The peri- and
epineural layers that surround and protect the nerve differ-
entiate from the surrounding mesenchyme in a process that
requires Schwann cell-derived desert hedgehog signaling
(Bunge et al., 1989; Du Plessis et al., 1996; Parmantier et al.,
1999).
The major defects in the developing and adult peripheral
nerves of claw paw mutant mice were originally described as
a general delay of myelination initiation and the persistence
of promyelin fibers in adult animals (Henry et al., 1991). On
the basis of these morphological observations, Henry et al.
hypothesized that the clp defect affects the complex signal-
ing between axon, Schwann cell and extracellular compo-
nents that control the transition of promyelin Schwann cells
into myelinating cells. Molecular studies have shown that
this transition is mediated by the activity of the transcription
factors Oct-6 and Krox-20 acting consecutively in the
Schwann cells (Ghislain et al., 2002). Our finding that clp
does not affect activation of Oct-6 expression but that Krox-
20 activation is delayed suggests that clp acts either down-
stream of Oct-6 or in a second non-redundant pathway.
Several observations presented here argue in favor of the
second possibility. Morphological examination of nerves of
newborn claw paw animals revealed that Schwann cells are
still at an early sorting stage of development while wild-type
and Oct-6 mutant Schwann cells are at the end of the sorting
stage. This early sorting stage observed in P1 clp/clp nerves
would be appropriate for embryonic nerves in E16–E18
wild-type embryos. Sorting and ensheathment of axons by
Schwann cells critically depends on rearrangements of the
Schwann cell cytoskeleton. Deletion of the h1 integrin or
the laminin g1 gene in Schwann cells results in impaired
sorting of axon bundles, suggesting that these rearrange-
ments are mediated through interactions between the extra-
cellular matrix laminins and their integrin receptors (Chen
A. Darbas et al. / Developmental Biology 272 (2004) 470–482 479
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and Strickland, 2003; Feltri et al., 2002; Saito et al., 2003).
The similarity in ultrastructural abnormalities observed in
newborn clp/clp, h1 integrin and laminin g1 mutant nerves,
suggests that clp acts in these pathways. In contrast to
laminin g1 null Schwann cells, clp/clp Schwann cells are
not permanently blocked at the sorting stage. It is therefore
likely that a clp redundant function exists or that the clp
allele is a hypomorph.
In addition, clp/clp nerves exhibit hyperfasciculation, a
phenotype resembling that observed in dhh mutant mice,
suggesting the possibility that this specific aspect of the claw
paw mutant phenotype results from downregulation of dhh
expression. In agreement with this suggestion, we found that
dhhmRNA is expressed at reduced levels in clp/clp nerves (at
P12). However, in contrast to dhhmutant animals, the nerve–
tissue barrier function of the perineurium in claw paw animals
is not affected (Fig. 2). As the biological effects of hedgehog
proteins are known to be dose-dependent, it is tempting to
speculate that the differences in phenotype between dhh
mutant and clp/clp nerves reflect differences in dhh expression
levels in the developing nerves of these two mutant animals.
Nuclear periaxin expression in embryonic Schwann cells,
and the later accumulation of periaxin in promyelin cells at
P8, is not observed in claw paw nerves at these stages (Figs.
2 and 3), although periaxin does eventually accumulate in
Oct-6 and Krox-20 expressing myelinating clp/clp Schwann
cells (Fig. 2). It has recently been suggested that a dual
mechanism of periaxin regulation exists in which Krox-20
amplifies an earlier Krox-20 independent activation of the
periaxin gene (Parkinson et al., 2003). Our results suggest
further that the early Krox-20 independent activation of
periaxin is regulated through a clp-dependent pathway.
Alternatively, it is possible that clp Schwann cells at E17
represent an earlier differentiation stage at which periaxin is
not expressed yet (they will have to be very early Schwann
cell precursors, as E14 Schwann cell precursors express
periaxin in their nuclei, (Sherman and Brophy, 2000). It is
unlikely that the absence of detectable levels of periaxin in
clp Schwann cells contributes significantly to the peripheral
nerve phenotype in claw paw mice, as peripheral nerve
development is morphologically normal in periaxin null
mice (Gillespie et al., 2000).
Thus, in contrast to what has been suggested earlier, the
clp mutation affects nerve development at a stage well
before the promyelin-myelinating transition. The particular
defects suggest that clp is involved in axon–Schwann cell
interactions that drive the invasion and sorting of immature
Schwann cells and the subsequent elaboration of a basal
lamina and myelination initiation.
On the nature of the claw paw mutation
In the absence of knowledge about the mutation under-
lying the claw paw phenotype, we do not know what
mechanism could account for the peripheral nerve develop-
mental defect and the behavioral defect in claw paw
animals. However, on the basis of the observed develop-
mental defects, the recessive nature of the clp mutation and
in particular the results of regeneration and nerve transplan-
tation experiments, we can speculate on possible scenarios.
Although the morphological abnormalities observed in the
nerve of claw paw animals suggest that the clp mutation
affects primarily Schwann cells, the transplantation and
nerve regeneration experiments suggest that clp function
might also be required in the neurone and possibly the
endoneurial fibroblasts. It is therefore likely that the clp
gene product is expressed and functioning in both Schwann
cells and neurones and that the clp mutation is not a gain of
function mutation. These suggestions are compatible with
clp functioning in, or regulating, homo- or heterophilic
interactions between axons and Schwann cells. For exam-
ple, it is possible that the claw paw protein is involved in
bringing adhesion molecules to the cell surface or that claw
paw itself is a cell surface protein directly involved in cell–
cell interactions. Alternatively, it is possible that the clp
mutation is a regulatory mutation affecting expression of
genes involved in the abovementioned interactions. These
impaired axon Schwann cell interactions at an early stage
could have repercussions for nerve activity during fetal
stages and affect the normal spontaneous movement of the
fetus, important for proper posture development.
In summary, we have provided evidence that the mouse
clp mutation affects the Schwann cell compartment and
possibly the neuronal compartment of the regenerating and,
by extension, the developing nerve, suggesting that the clp
gene is expressed in Schwann cells and neurones and is
involved in direct axon–Schwann cell interactions. Further-
more, the clp mutation affects early activation of periaxin
expression and Krox20 expression in Schwann cells, but
does not affect the signaling pathway that activates Oct-6
expression, suggesting that axonal signals that initiate
myelination are transduced through multiple parallel, non-
redundant pathways.
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Abstract
Mice homozygous for the autosomal recessive mutation claw paw (clp/clp) exhibit 
limb posture abnormalities and congenital hypomyelination of the peripheral nervous 
system but not the central nervous system. Within the peripheral nervous system 
promyelin figures are observed, indicating a myelination delay. During differentiation, 
Schwann cells become polarized and myelination is initiated at the end stages of 
Schwann cell polarization. The process of polarization is characterized by expression 
of laminin and the myelin proteins MAG, P-zero and periaxin.  We have previously 
shown that expression of P-zero and periaxin is delayed in clp/clp Schwann cells. 
However, the precise cellular localization of periaxin remained unclear. Periaxin is 
indirectly linked to laminin, an essential component of the basal lamina. While periaxin 
could not be detected in the nuclei or cytoplasm of embryonic clp/clp Schwann 
cells, periaxin was found to be present in myelin when it first appears during the 
second and third postnatal week of development. Additionally, we found that laminin 
expression was delayed. We hypothesize that the clp mutation impairs Schwann cell 
polarization, resulting in delayed entry into the promyelin and myelinating phase of 
cell differentiation.
  
Introduction
Dysmyelination in claw paw
Claw paw (clp) mice are characterized by congenital limb contractures and 
dysmyelination of the peripheral nervous system (PNS) [1]. Several studies have tried 
to clarify the claw paw phenotype [2, 3] and some have excluded mutations in genes 
involved in myelination, like Mag, as causative of claw paw [4]. A majority of Schwann 
cells in clp/clp nerves are at the promyelin stage of cell differentiation at postnatal day 
14 (p14) [1, 2]. This stage is characterized by the upregulation of Mag, downregulation 
of neural cell adhesion molecule (NCAM), and immature pattern of sodium channel 
clustering at the nodes [2]. In clp/clp nerves, P-zero mRNA expression is found at 
normal levels at p1.5 [3], while expression of the fatty acid binding protein (P2), of 
a cytoskeletal protein (dendrin) and the cysteine rich protein 2 (CRP-2) are delayed 
[3]. 
The axonal signals that govern myelin gene expression and initiate myelination 
remain largely uncharacterized [5]. Normally, myelin protein constituents start to be 
synthesized by the Schwann cell after it contacts one single large calibre axon at 
the end of the radial sorting process [6-8]. The transcription factors Krox-20 and 
Oct-6 are both important regulators of the myelination process. Despite similarities 
in peripheral nerve pathology between claw paw and Oct-6 null and Krox-20 null 
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mutants, limb abnormalities are not observed in the latter two mutant mice [9-11]. 
Limb posture abnormalities are an important feature of newborn mice in which 
the gene encoding the kinesin protein KIF1B β is homozygously deleted. KIF1B β is 
involved in anterograde axonal transport of synaptic vesicles and mitochondria, hence 
in cellular polarization. In these KIF1B β -/- mice an ATP binding site of the Kif1B β 
protein is disrupted,  affecting both axonal transport and polarisation [12]. Disruption 
of KIF1B β results in progressive nerve degeneration and central nervous system 
abnormalities [12]. This differs from claw paw, where central nervous development 
is unaffected and the claw paw phenotype improves over time. However, the limb 
posture abnormalities become fixed contractures in severely affected mice [1]. Fixed 
contractures have not been described in KIF1B β mice. 
Congenital contractures (arthrogryposis) in humans can be a feature of 
neuromuscular impairment during development. In addition, arthrogryposis has been 
associated with congenital hypomyelination [13]. Mutations in P-zero [14] , Krox-20 
or PMP-22 have been described as cause of central and peripheral hypomyelination 
[15-18]. Impaired myelination throughout peripheral nervous system, in particular 
Schwann cell arrest, has been reported in these disorders [19-23]. Therefore, the 
study of the clp/clp dysmyelination serves as a model for human diseases. 
Myelination proceeds from Schwann cell differentiation and polarization
Prior to myelin synthesis, Schwann cell become polarized. Cellular polarization 
creates cellular asymmetry, through site-specific expression of proteins along its cell 
surface. Thus, typical epithelial cells have a basal and apical membrane, each with 
specialized function. Similarly, Schwann cells have an adaxonal membrane (facing 
the axolemma) and an abaxonal membrane (facing the endoneurium). One of the 
characteristics of Schwann cell polarization is the formation of a basal lamina at the 
abaxonal surface. Although current evidence suggest that basal lamina formation 
critically depends on direct axonal contact, some studies suggest a diffusible neuronal 
factor can induce a patchy basal lamina [24, 25]. One of the constituents of the basal 
lamina is the extracellular matrix molecule laminin [26, 27]. 
Within the Schwann cell an intracellular shift of Mag [26, 28], P-zero [26] and 
periaxin [8, 29, 30] is observed during Schwann cell differentiation. Therefore, the 
expression of Mag [30], P-zero [26] and periaxin [30, 31] proteins is considered an 
indicator of Schwann cell polarisation. 
The periaxin gene encodes at least two proteins; a full length form, L-periaxin, 
and a truncated isoform, S-periaxin. Both proteins have a PDZ motif (post-synaptic 
density protein PSD-95, Drosophila discs large (dlg) tumor suppressor gene and the 
tight junction-associated protein ZO-1), found in a growing family of proteins. PDZ 
domain proteins might organize and transduce signals at sites of cell-cell contact. 
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Since these proteins shuttle between the cell surface and the nucleus it was believed 
that some PDZ domain proteins were transmitting signals between the cell surface and 
the nucleus. In fact L-periaxin is targeted to the nucleus of embryonic Schwann cells, 
whereas in mature myelinating Schwann cells it is localized at the plasma membrane 
[32]. As a cytoskeletal linker protein [33], periaxin is linked to laminin via dystrophin-
related protein (DRP2), which in turn is associated with dystroglycan [29, 34]. 
In peripheral nerves, axons are individually and collectively ensheathed by 
respectively Schwann cells (endoneurium) and perineurial cells. Both endoneurial 
and perineurial basal lamina consists of laminins. Laminins consists of α, β and γ 
chains, each encoded by distinct genes. Laminin-2 (α2β1γ1), also referred as s-
laminin or merosin, is predominantly found in muscle and peripheral nerve [35]. The 
role of laminin in Schwann cell myelination has been highlighted by studies on the dy/
dy mouse. In the laminin defective, dy/dy mutant mouse, mRNA expression levels of 
the laminin gene are reduced. Similar to patients suffering from congenital muscular 
dystrophy (CMD), these mice exhibit muscular weakness [36, 37]. The spinal nerves 
of dy/dy mouse are characterized by a reduced number of myelinated axons, atypical 
patterns of Schwann cell ensheathment and amyelination. In addition, the basal 
lamina around Schwann cells is discontinuous. Abnormalities in peripheral nerves 
are probably due to the absence of this extracellular matrix molecule. Contrary to 
expectations, laminin deficient mice do myelinate [38]. Apparently, in the absence of 
laminin myelination is merely delayed. One additional feature of dy/dy Schwann cells 
is the lack of polarization [39].
Schwann cell polarization in claw paw
Previous studies of Oct-6 null mice, have revealed an arrest at the promyelin stage 
of Schwann cell differentiation with normal expression of both laminin and periaxin, 
[10] but delayed Krox-20 expression [40]. In clp/clp mutant mice expression of P-zero 
and periaxin is delayed in addition to Krox-20 expression [41]. In the present study, 
we describe the expression of laminin in clp/clp nerves by immunohistochemistry. In 
addition, basal lamina formation is studied by electron microscopy in order to elucidate 
the sequence of events underlying initiation of myelination. 
Materials & Methods
Immunohistochemistry
Wildtype and clp/clp nerves were isolated at postnatal day 8 (P8) and at embryonic 
day 17½ (E17.5). Nerves were fixed in 35% methanol, 35% acetone, 5% acetic acid 
and 25% H2O. After dehydration and paraffin embedding, 7-μm sections were cut and 
mounted on gelatin coated microscope slides. 
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Antibody incubations were performed in PBS/0.05% Tween-20/1% BSA. Primary 
antibody was used at a dilution 1:10000 (periaxin); neurofilament medium chain (1:200, 
Hybridoma 2H3, Developmental Studies Hybridoma Bank) and undiluted supernatant 
of the s-laminin (Clone C4), and incubated overnight at room temperature. After 
extensive washing, sections were incubated for 2 hours at room temperature with 
oregon green coupled goat anti-rabbit secondary antibody and with texas red goat 
anti-mouse secondary antibody (Molecular Probes). 
Electron microscopy
Wild type (Oct-6 +/ΔSCE) and claw paw animals were perfused with PBS for 3 minutes 
followed by fixative (3% PFA (Sigma); 1% glutaraldehyde in 100 mM cacodylatebuffer 
pH 7.2) for 10 minutes. Sciatic nerves were isolated, washed with cacodylate buffer, 
osmicated in 1 % osmium tetra-oxide and embedded in Epon. Semithin sections 
(1μm) of Epon embedded sciatic nerves were mounted on glass slides and stained 
with methylene blue. Thin cross sections from the sciatic nerves were cut and uranyl 
acetate and lead citrate stained for electron microscopy.
Results
Adaxonal periaxin expression and delayed laminin upregulation in postnatal 
claw paw nerves
Similar to Oct-6 null mutant nerves, clp/clp nerves display congenital hypomyelination 
with many Schwann cells at the promyelin stage one week after birth. In Oct-6 null 
nerves P-zero protein expression is delayed, while upregulation of periaxin and laminin 
is normal. We studied the expression of these proteins in clp/clp nerves at postnatal 
day 8. We collected sciatic nerves of wildtype, and clp/clp nerves and myelination 
was analysed morphologically by light microscopy. Expression of periaxin (Fig 1) and 
laminin (Fig 2) was studied by immunohistochemistry. As shown in wildtype nerves, 
(Fig 1A) a ring-like structure characteristic for myelin is observed. At postnatal day 8, 
the staining pattern of clp/clp nerves does not structurally resemble myelin, (Fig 1B). 
We further analysed the expression of periaxin by confocal microscopy. This analysis 
revealed periaxin expression at the adaxonal membrane in both wild type and clp/clp 
nerves, consistent with its normal expression pattern (Fig 1C, D).
Since laminin expression was unaffected in Oct-6 null mouse [10], we studied 
laminin expression in wild type nerves (Fig 2A) and clp/clp nerves (Fig 2B) at postnatal 
day 8 and 16.
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Laminin expression is aberrant in clp/clp nerves with characteristic staining of 
minifascicles (perineural cells also elaborate a basal lamina). These minifascicles are 
a characteristic feature of clp/clp nerve [1] (Fig 2B). Endoneurial laminin associated 
with the Schwann cell basal lamina is eventually found in clp/clp mice at postnatal 
day 16 (Fig 2D). We further analysed the formation of the basal lamina by electron 
microscopy.
Figure 1. Adaxonal expression of 
periaxin in both wildtype and clp/
clp mice. Transverse sections of P8 
sciatic nerve from wildtype (A, C), and 
clp/clp (B, D), animals stained with 
an periaxin antibody and visualized 
using confocal microscopy. 
Figure 2. The expression 
of laminin was analysed by 
immunohistochemistry in both 
wildtype and clp/clp sciatic 
nerves, at two distinct postnatal 
stages (p8 and p16). 
Axons are individually and 
collectively ensheathed with a 
basal lamina in wildtype nerves 
at both postnatal days 8 (2A) 
and 16 (2C). Conversely clp/
clp axons are predominantly 
collectively ensheathed at P8 
(2B), eventually at P16, axons 
are individually ensheathed 
(2D). 
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Whereas in control nerves (Oct-6 +/ΔSCE), an extracellular matrix is clearly visible at 
P8 (Fig 3 A, C), clp/clp nerves deposit an extracellular matrix later (Fig 3 B, D). 
Delay of laminin expression in developing nerves of claw paw
Previous studies have shown that expression of P-zero is not affected in sciatic nerves 
of E18 Oct-6 null embryos [9], while at P8 expression of P-zero is reduced in Oct-6 null 
nerves [9, 40]. This means that embryonal stages of Schwann cell development are 
not affected by the Oct-6 mutation. In contrast, in clp/clp nerves delayed expression 
of P-zero is observed [41]. The induction of high levels of P-zero gene expression in 
differentiating Schwann cells is correlated with the initiation of myelin formation and 
the formation of a basal lamina [42]. 
To determine the effects of the clp mutation on the expression of laminin, 
we used antibodies directed against laminin and neurofilament to study laminin 
expression in tissue sections of E17 clp/clp nerves (Fig 4). Histology showed that 
while in control nerves individually and collectively a basal lamina was formed around 
axons, (Fig 4A,C) the expression of s-laminin (merosin) was reduced and restricted 
to the perineurium in clp/clp nerves (Fig 4B, D). These data indicate that expression 
Oct-6 +/SCE Claw paw
P8
P12
A B
C D
Figure 3. The formation of a basal lamina was analysed with electronmicroscopy in both wildtype (Oct-6 
+/ΔSCE) and clp/clp sciatic nerves at two different postnatal stages (P8 and P12).
Axons are ensheathed with a basal lamina in both genotypes, indicated with arrows. Myelination is well 
advanced at both P8 (3A) and 12 (3C). In contrast, clp/clp axons are just secreting a basal lamina at P8 
(3B), eventually at P12, axons are individually ensheathed and myelination commences (3D; arrows).
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of laminin, which is dependent on axonal contact, is delayed in embryonic stages of 
developing clp/clp nerves. 
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Figure 4.  Wildtype nerves are compared with clp/clp nerves at embryonic day 17 ½ (E 17 ½ ). 
Wildtype nerves express neurofilament (4C), and laminin (4A) antigens. But clp/clp nerves only express 
neurofilament (4B) and initiate laminin (4D) expression. 
?
Laminin
?
Claw paw
Figure 5. Schematic representation 
of the cascade induced by clp when 
myelination is initiated. Myelination 
is under control of continued 
axonal signaling. One important 
target of this signaling is the clp 
gene, whose function is probably 
required for axo-glial interactions 
that govern cellular polarization. 
Important targets of clp signaling 
are Krox-20, P-zero, periaxin and 
laminin, as upregulation of these 
genes are delayed in the absence 
of clp. (Adapted from [45])
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Discussion
Claw paw: transient arrest in Schwann cell polarisation? 
The delayed expression of Mag [2], P-zero, laminin and periaxin, all proteins involved 
in polarization, implies that delayed myelination in clp/clp mice is associated with 
impaired Schwann cell polarization. Evidence for a transient arrest of Schwann cell 
polarization in clp/clp nerves comes from the following observations: 1) abnormal and 
delayed formation of a basal lamina, 2) delayed expression of Mag [2] and P0 [41], 3) 
delayed expression of periaxin during embryonal development as far as its nuclear 
expression is concerned [41]. 
We have previously shown that in clp/clp nerves Oct-6 expression is 
unaffected during pre- and postnatal development. However, expression of Krox-20 
and myelin proteins such as Mag [2], P-zero and periaxin is delayed [41]. The results 
of immunohistochemistry experiments on nerve sections indicate that the clp gene 
acts either downstream or, more likely, parallel to Oct-6 and upstream of Krox-20 [41]. 
Myelin formation is controlled by axon-associated cues that regulate a genetic program 
of gene expression involving the transcription factors Oct-6 and Krox20 (see figure 5). 
These intra-cellular signaling pathways converge, at least in part, on the Oct-6 Schwann 
cell enhancer some 10kb downstream of the transcriptional start site. In turn, Oct-6 
regulates Krox-20 expression, probably directly via the Krox-20 myelinating schwann 
cell enhancer (MSE). Krox-20, a key transcription factor, regulates a set of genes 
including periaxin, P-zero and laminin [43]. However, early embryonic expression 
of periaxin is independent of Krox-20 [44]. Periaxin belongs to the family of PDZ-
domain proteins, which are considered to transmit regulatory signals between the cell 
surface and the cell nucleus [32] and to be regulated by a nuclear localization signal. 
Indeed, periaxin is found in nuclei of Krox-20 null embryonic Schwann cells [44]. The 
significance, if any, of nuclear L-periaxin expression remains to be elucidated [32]. As 
initial myelin formation appears relatively normal in periaxin homozygous null mice, it 
is unlikely that the lack of periaxin expression in embryonic clp/clp nerves is causally 
involved in the radial sorting and myelination delay in these mice. The basal lamina is 
normally formed in Krox-20 and Oct-6 null nerves. In contrast, basal lamina formation 
appears delayed in clp/clp nerves. Since the Schwann cell, and not oligodendrocytes 
secrete a basal lamina, the delayed basal lamina formation could explain why in clp/
clp mice mainly the PNS is affected and not the CNS. Apparently, the clp gene acts in 
a pathway which influences  expression of the extracellular matrix molecule laminin. 
Basal lamina formation is a result of axo-glial communication by both axonal signaling 
and a soluble factor [24, 25]. Hence, the clp gene might be required during axo-glial 
communication or alternatively it is a soluble factor. 
Normally, periaxin and Mag precedes P-zero [31] protein expression. The 
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latter is considered normal in terms of mRNA transcription levels in clp/clp nerves at 
p 1.5 [3]. If we assume that mRNA expression in clp/clp mouse mutants is normal, 
this would indicate that the clp gene influences unknown posttranscriptional control 
mechanisms. 
From our experiments, insight is achieved with respect to localization of 
periaxin expression and basal lamina formation in the clp/clp mutant. Clp acts most 
likely parallel of Oct-6 and upstream of Krox-20, periaxin and laminin [41] (Figure 
5). Clp/clp and Oct-6 null mouse mutants are similar in that both exhibit a transient 
defect in Schwann cell differentiation. Whereas an Oct-6 mutation transiently arrests 
the Schwann cell in myelination, clp probably does so by disrupting radial sorting and 
cell polarization. 
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Positional cloning of claw paw
Abstract
The claw paw (clp) mouse mutant exhibits striking nonfixed limb posture abnormalities 
and  congenital hypomyelination throughout the peripheral nervous system but not 
the central nervous system. Following a previous report, describing the linkage of clp 
locus on mouse chromosome 7, we have undertaken a positional cloning approach to 
identify the clp gene. Genetic mapping through linkage analysis resulted in refinement 
of the region in the vicinity of the Gpi-1 locus to an area of approximately 737 kb. 
In this area 41 defined and/or predicted genes and proteins were localized when 
this study was initiated. Among these genes, three were selected for further study. 
These genes, Scn1b, Fxyd3 and Fxyd7, were found to be expressed in Schwann cells. 
No mutations in the ORF or splice junctions were detected in any of these genes 
excluding them for now as clp candidate genes. However, reduced mRNA expression 
of at least three genes was observed in clp nerves, suggesting that clp might function 
as a regulator of PNS genes.
Introduction
Claw paw (clp/clp) mice with abnormal front paws (flexion at one or more joints) 
were noticed in 1977 within a litter of C57Bl/6J-obese inbred strain [1]. Subsequently 
matings with unrelated non-obese C57Bl/6J mice were established to discard the 
unwanted obese gene. The genetic defect showed autosomal recessive inheritance 
[1]. The severity of the phenotype was very variable. In some animals only one of 
the forelimbs is affected (flexion of a paw), while more severely affected animals 
show abnormalities in both forelimbs (forelimb held along the thorax) and one of the 
hindlimbs [1].
If clp/clp mice survive the first several weeks of age, which mainly depends on the 
severity of the phenotype, their condition improves over the months except that the 
non-fixed posture abnormality develop into a fixed contracture [1]. 
Thus, the autosomal recessive clp/clp mouse mutant exhibits nonfixed limb 
posture abnormalities, which are detectable at late embryonic stages and the first 
postnatal days. Ultrastructural studies have shown that small caliber axons are 
blocked in myelination and the Schwann cells are arrested in the promyelin stage [1]. 
Minifascicles are observed in the peripheral nerve similarly to the desert hedgehog 
(dhh) knock-out phenotype [2]. In addition, nodal frequency in clp/clp mouse is altered, 
while sodium channel clustering has not yet occurred at P14 [3], leading to decreased 
nerve conduction velocity [4]. 
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Congenital contractures have been reported, in patients with congenital 
hypomyelination, a subset of hereditary motor and sensor neuropathy (HMSN) [5-7]. 
Only in very few cases is the genetic cause of the hypomyelination known. Congenital 
posture abnormalities occur in the heterogeneous group of arthrogryposis multiplex 
congenita (AMC), where virtually any condition resulting in decreased fetal movement 
can cause fixed contractures [8-10]. Among these conditions, only a few are linked 
to impairment of peripheral nerve myelination, without abnormalities of myelination in 
the CNS [11, 12]. 
Several mouse mutants, including trembler [13], dystonia [14] and quaking [13] exhibit 
dysmyelination in the peripheral nervous system. In contrast with these mouse 
mutants, clp/clp mutants exhibit limb abnormalities in addition to dysmyelination [1]. 
Whereas no central dysmyelination is reported for both trembler and dystonia, CNS 
myelin abnormalities are observed in the quaking mouse mutant. Trembler mutants 
are models for human peripheral neuropathies, in particular CMT1A [6, 15, 16], 
dystonia and quaking are not associated with a particular human disease.  
  The KIF1B beta (kinesin protein involved in anterograde axonal transport of 
synaptic vesicle precursors and mitochondria) [17] exhibits, similarly to clp, congenital 
limb posture abnormality in homozygous (lethal) and heterozygous pups. However, 
in contrast to clp, KIF1b beta gene null mutations affect central nervous system 
development. In addition, affected mice gradually acquire a staggering gait after one 
year of age [17]. In this respect the KIF1B beta null mutants show signs of progressive 
degeneration, a feature not present in clp/clp mice.
The clp/clp mouse can therefore be considered a good model for studying 
early stages of PNS myelination processes and to elucidate the relationship between 
congenital contractures and PNS dysmyelination. 
It is nowadays very well established that myelination results from interactions 
between constituent cells (axons and Schwann cells) of the peripheral nervous 
system [18]. Myelinating Schwann cells are involved in regulation of axonal properties 
and mediate for example spacing of sodium channels, which cluster in the nodes 
of Ranvier during development [19]. Conversely, axonal signals are involved in the 
initiation of myelination. Therefore mouse mutants with impaired myelination, either 
spontaneously arosen or engineered, help us to understand the interactions between 
axons and their surrounding glial cells (Schwann cells) [16]. Extensive research over 
the last decade has elucidated some of the mechanisms and molecules involved in 
the interactions between axons and glial cells. 
Two transcription factors, Oct-6 (POU domain transcription factor also referred as 
SCIP/Tst-1) and Krox-20 (a zinc finger transcription factor also known as Egr-2) have 
been shown to be pivotal in initiation of myelination. While Oct-6 is required for timing 
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[20, 21] and acts genetically upstream of Krox-20, the latter seems to be integral to 
the myelination program [22]. Hence, absence of the Oct-6 gene result in a transient 
arrest of myelination, while disruption of Krox-20 gene is associated with a permanent 
block of myelination, at least for the time period studied (up to postnatal day 15) [20-
23].
The similarity between the ultrastructural findings (arrest in the promyelin 
stage) in the peripheral nervous system of clp/clp [1] and the reported findings in 
Oct-6 [20, 21] and Krox-20 [22] implied that clp could fit in the already established 
genetic hierarchy [24]. In order to put clp in this hierarchy we aimed at identifying the 
clp gene via positional cloning. Linkage studies placed clp gene near the Gpi-1 locus 
on chromosome 7 [1].
Our efforts led to a reduction of the area of clp gene.
Materials & Methods
Mouse breeding 
Heterozygous clp/C57Bl6 mice, obtained from the Jackson laboratory were bred and 
in the progeny clp homozygotes were selected for their posture abnormalities at birth 
detectable within postnatal day 2 (P2). Clp/clp homozygote female mice were mated 
to BalbC (+/+) male mouse, and the resultant +/clp F1 progeny was intercrossed. In 
general the clp strain was maintained either by mating homozygote clp females with 
their +/clp brothers or by intercrossing +/clp individuals. In addition to get more BalbC 
in the strain from each F1, a clp female was again mated with a pure BalbC male. To 
confirm the genotype “each” clp animal was autopsied and characterized by analysis 
of sciatic nerves which are thinner. 
Genotyping 
Genotyping was performed by PCR on extracted tail DNA using three different 
STS markers: one in the vicinity of clp (D7MIT155) and the other two on either side 
(D7MIT77 and D7mit270) to define a region of non-recombinant STS markers. 
Whenever a recombination was found, the additional markers in between (D7MIT117; 
D7MIT308; D7MIT25) were tested to define the recombination region. To obtain a 
detailed version of the recombination region, another set of markers were selected 
and tested (D7MIT246;D7MIT344;D7MIT343;D7MIT155;D7MIT224;D7MIT308;D7M
IT79;D7MIT225;D7MIT78;D7MIT25).
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Dna fluorescent in situ hybridisation
Fiber FISH analysis was used to identify the relative localization of D7MIT155 and 
D7MIT224 (the non-recombinant STS markers) to each other on mouse chromosome 
7. The following double linked YAC clones containing these non-recombinant markers 
were obtained from: WC-930 clone 309-G-9 and clone 193-B-10 (D7mit 155) http//
www.informatics.jax.org/searches/contig.cgi?537 and WC-931 clone 421-B-8 (D7mit 
224) http//www.informatics.jax.org/searches/contig.cgi?2028. YAC DNA was isolated, 
the presence of STS marker in this particular clone confirmed and the DNA was used 
to hybridise with mouse genomic DNA. 
FISH analysis was performed as described by Mulder et al.[25] 
The probes were labeled with biotin and digoxygenin and immunochemically detected 
with fluorescein and Texas red. The DNA was counterstained with DAPI. 
Expression analysis
Total RNA was isolated of sciatic nerves, heart and testis, spinal cord and muscle of 
8-11 days, using TRIzol reagent (Gibco BRL). RT-PCR was performed with primers 
generated for cDNA of Scn1b (forward TGGAGGTGGATTCCGATACC; reverse 
GCCACAAGCCATATGGTCAAC), Fxyd3 (forward AACCACCTCTCAGCCTGTTGA;
reverse ACAAAGAGCCTGCTACCACGA) and Mag (forward GCCACGGTCATCTAT
GAGAGTCAGC; reverse GGTGCCCCAGAGATTCTGAATTCGG). 
Mutation analysis
Each exon of the selected genes (Scn1b, Fxyd3, Fxyd7, see results section) within 
the clp area was amplified separately using primers complementary to flanking 
intronic sequence. DNA sequences can be found in the appendix. After confirming 
the PCR product size, the product was send to a sequencing company Baseclear for 
sequencing.
Results
The clp gene had previously been mapped to mouse chromosome 7 near the Gpi-
1 locus (Fig 1A). Several STS markers surrounding the clp locus were selected 
(Fig 1B). To increase the resolution of the map around clp, crosses were expanded 
to a total number of 190 progeny clp/clp mice (380 meiotic chromosomes). After 
having established an initial order for these STS markers on a panel of 120 meiotic 
chromosomes, several markers could be discarded, as their recombination rate 
(distance) was too high (Fig 2). Genotyping an additional 130 clp/clp animals (260 
meiotic recombination events) resulted in a genetic map with 4 non-recombinant STS 
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markers (D7mit343, D7mit155, D7mit224, D7mit308) flanked at the centromeric site 
by D7mit344 (1 recombination) and at the telomeric site by D7Mit79 (1 recombination) 
(Fig 2).
Figure 1. (A) Genetic map of the clp locus at the start of our study (B) Selection of STS markers in the 
vicinity of clp locus. Furthermore, genes localized on chromosome 7 are shown. Gray color indicates no 
recombination found with this specific STS marker with linkage analysis. Bold indicates STS markers 
where one or more recombinations have been found.
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Figure 2. Recombination scores
Recombination was scored by selection of Balb/C alleles for a specific STS marker in a clp/clp animal. 
As clp/clp originates from C57Bl/6J background while the inheritance is autosomal recessive, any Balb/C 
allele, in a clp/clp mutant, for a marker indicates that this specific STS marker is not linked to clp.
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YAC clones were ordered to determine the size of the insert via pulsed field 
gel electrophoresis. After having confirmed the presence of the STS marker in the 
YAC DNA, we wanted to know whether these YAC clones contained overlapping 
stretches of DNA. Fiber FISH analysis revealed that the YAC clones were overlapping 
with the STS marker D7mit 224 containing YAC clone telomeric from the YAC clone 
containing the STS marker D7mit155 (Fig 3), consistent with information in the mouse 
genome informatics database. After release of the mouse genome draft sequence 
(2002), we pursued our research by looking for candidate genes instead of working 
with YAC clones.
Having identified four non recombinant markers in the genome (D7mit344, 
D7mit155, D7mit224 and D7mit308), we used these genome sequence data to define 
a region within the available databases, such as Celera http://www.celera.com, 
Ensembl http://www.ensembl.org, UCSC http://genome.ucsc.edu  and NCBI http://
www.nlm.nih.gov . This was still an area of 3.69 Mb according to Ensembl jun 2004.
In the meantime, a recombination between Cast/Ei and C57Bl/6J in mouse 27R 
was identified by our collaborators. Phenotypically wildtype offspring were either 
heterozygous Cast/ei/C57Bl/6J for centromeric markers (D7mit266, and D7mit246) 
Figure 3. Fiber FISH analysis
FISH analysis was performed to localize the non-recombinant STS markers D7mit224 and D7mit155 to 
each other throughout the mouse genome. With red color the YAC clone containing D7mit155 and with 
green color the YAC clone containing D7mit224 is indicated. Furthermore is the color green used for 
localization of the telomeres, while blue shows the centromer. 
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and homozygote C57Bl/6J for telomeric markers or heterozygote C57Bl/6J, while 
the clp/clp offspring of this mouse was exclusively homozygote C57Bl/6J for the 
investigated STS markers. This result implicated that a recombination had occurred 
in mouse 27R between clp and D7mit155 (Fig 4).
Thus these data demonstrate that clp  is localized on the centromeric site of D7mit155. 
This recombination in that specific mouse reduced the area of 3.69 Mb to approximately 
737 kb (736724 basepairs) consisting of 41 defined and predicted genes. Furthermore, 
clp is localized in between D7mit344 (centromeric)  and D7mit155 (telomeric). Only 
the STS marker D7mit343 remained non recombinant from the 4 non-recombinant 
STS markers (see Fig 5 next page). This region is compared with the syntenic region, 
localized on chromosome 19, in the human genome database. The genes are similar 
in the human syntenic region, only the order is reversed. In an area of approximately 
821 kb (821036 bp) 130 defined and predicted genes/proteins are localized.
Figure 4. Crossing of Cast/Ei with heterozygote C57Bl/6J resulting in the offspring 27R Cast/Ei was crossed 
with a heterozygote clp/clp in the C57Bl/6J background. Offspring of these mice were heterozygote for 
Cast/Ei/C57Bl/6J background and claw paw. Subsequently these mice were crossed with a heterozygote 
claw paw in the C57Bl/6J background. All the offspring were tested for the selected STS markers shown 
in right corner. Among tested animals 27R had a striking genotype. This mouse was at the centromeric 
site heterozygote for Cast/Ei and C57Bl/6J background while at the telomeric site it was homozygote for 
C57Bl/6J background. This mouse was phenotypically wildtype. 27R was crossed with a heterozygote 
claw paw in the C57Bl/6J background and the offspring of these mice were as following: wildtype mice 
had either the same genotype as 27R or were homozygous C57Bl/6J while clp/clp mice were exclusively 
homozygous C57Bl/6J indicating that in 27R a recombination had occurred between clp and D7mit155. 
This mouse places clp on the centromeric site of D7mit155.
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From this collection of candidate genes a small number of genes were selected. 
These genes encode proteins expressed in the peripheral nervous system and which 
are involved in generation of action potentials (Scn1b [26]), or in maintenance of 
membrane potential Fxyd3 [27] and Fxyd7 [28]). The selected genes are at a distance 
of 127 kb from each other within the clp area on chromosome 7. Each exon of these 
selected genes, with the flanking splicing regions, were amplified from clp/clp genomic 
DNA. No mutation was found in either the protein coding part of the gene or in the 
splice junction sequences.
Figure 5. The clp area as defined by linkage analysis.
Via linkage analysis a certain region is defined. Additional data of transcripts, genes and proteins within 
this area are derived from the mouse genome databases: Celera, NCBI, UCSC and Ensembl.
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Additionally, Scn1b, Fxyd3 and Mag (myelin associated glycoprotein) were tested for 
the levels of mRNA expression. We selected Mag for RT-PCR rather than Fxyd7, as 
Fxyd7 had a weak expression already in control nerve. Mag, localized on chromosome 
7 in the vicinity of clp, a minor constituent of CNS and PNS myelin, was already ruled 
out as a candidate gene for clp via sequencing cDNA [29]. Furthermore, the Mag 
knock-out mouse had a phenotype distinct from clp [30, 31]. The reason why we 
preferred analysing Mag was based on a study where expression of Mag preceded 
sodium channel clustering [32]. Therefore, we were interested in the expression of 
Mag during development of the peripheral nervous system in clp/clp where sodium 
channel clustering had not yet occurred [3]. By RT-PCR a reduction of mRNA 
expression of voltage gated sodium channel (Scn1b) and chloride channel or chloride 
channel regulator (fxyd3 = mat 8) and Mag was observed at postnatal day 8-11 clp/clp 
nerves (Fig 6).
No reduction of control gene expression (hypoxanthine phosphoribosyl-transferase 
=HPRT) was observed in the same experiments. To see whether reduction in mRNA 
level of Scn1b, Fxyd3 and Mag was a general phenomenon in clp/clp mice or restricted 
to the peripheral nerves, other tissues were included. Heart and testis (Scn1b), muscle 
(Fxyd3) and spinal cord (Mag) were selected. We did not found a similar reduction 
as observed for peripheral nerves (not shown) suggesting that the downregulation of 
these genes is Schwann cell specific. 
Figure 6. Ethidium bromide stained acrylamide gel with final cDNA product of genes shown below. 
Quantitative RT-PCR has elucidated that expression of Scn1b, Fxyd3 and MAG are reduced if compared 
with HPRT. 
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Discussion
In the present study we sought to further define the position of the clp gene through 
increasing the resolution of the genetic map and to identify the genetic defect underlying 
the claw paw phenotype. We have demonstrated that the clp gene is between the 
markers D7mit155 and D7mit344, spanning an area of approximately 737 kb. We 
selected three candidate genes in this area for their expression in the peripheral 
nervous system, adhesive function combined with generation of action potentials 
(Scn1b) [26] and maintenance of membrane potential (Fxyd3 [27] and Fxyd7 [28]). No 
mutations were found in these genes. However, we observed reduced mRNA levels 
in clp/clp nerves for the genes encoding MAG, Fxyd3 and Scn1b. All these genes are 
present at or near the clp area, and while Fxyd3 and Scn1b were clp candidate genes, 
Mag was not. 
Although our data of reduced mRNA levels for several of these genes have 
to be confirmed by either northern blot experiments or in situ hybridisation, a recent 
report indicate that it is very likely that clp affects more genes at the mRNA level. 
RNA in situ hybridisation analysis suggest that the genes encoding P2, a myelin 
component and member of the fatty acid binding protein, dendrin and the LIM-domain 
protein cysteine rich protein-2 (CRP-2) are all expressed at reduced levels in the 
sciatic nerve of clp/clp animals [33].
The fact that the reduced genes within the defined clp area are at a distant 
of 308 kb from each other implicates that there is an underlying mechanism which 
regulates gene expression in this area. We speculate that this mechanism depends 
on clp. Alternatively, the reduced expression of these genes reflect the delayed 
sorting and myelination observed in clp/clp nerves. A developmental profile of gene 
expression of all these genes in wildtype and clp/clp animals need to be obtained to 
resolve this issue. 
An example of a similar global effect on gene expression levels of a selected 
group of genes is provided by quaking. Quaking is a mouse mutant with generalized 
hypomyelination throughout the central and peripheral nervous system [13]. Quaking 
is associated with reduced expression of several myelin genes including Mag [34], 
proteolipid protein (PLP), Myelin basic protein (MBP). The Quaking I (QKI) protein 
belongs to the family of STAR proteins (signal transduction activator of RNA 
metabolism) and the reduction of many myelin proteins at the mRNA level seems 
to be associated with impairment of mRNA metabolism. A recent investigation 
addressed the question whether QKI interacts with mRNAs of myelin proteins to 
regulate homeostasis, or whether posttranscriptional misregulation interrupts normal 
myelination [35, 36]. Indeed, destabilization and mislocalization of at least MBP 
mRNA is reported [36]. Furthermore, a series of N-ethyl-N-nitrosurea (ENU)-induced 
quaking alleles established that quaking is essential in embryonic development where 
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it was required for blood vessel formation [37]. A similar mechanism as observed 
in quaking could be the underlying mechanism in clp where instead of the central 
nervous system the peripheral nervous system is affected. 
The limb abnormality observed in clp/clp is strikingly similar to KIF1b beta mouse 
mutant with a disruption in axonal transport implicating that clp/clp could have a 
neuronal component.
Indeed a neuronal component is not excluded in our results. However, progressive 
axonal degeneration would have ultrastructurally resulted in degeneration/regeneration 
phenotype, which was not observed [1]. 
The yet undefined clp gene is localized in the 737 kb region on chromosome 
7 defined in this study. Mutation analysis of each of the 41 genes in this area would 
be the most direct way to identify the clp gene. Even when a mutation is found which 
disrupts the open reading frame of one of the genes additional experiments need 
to be done to confirm that this mutation is causing the phenotype as no additional 
clp alleles are known. The most obvious one would be a genetic complementation 
experiment. However, if the genetic defect underlying clp is a mutation in a regulatory 
region the absence of additional clp alleles severely limits our chances of identifying 
the mutation. In this case the mapping will have to be further refined analysing much 
larger numbers of meiotic chromosomes, to be able to sequence directly the minimal 
critical region of claw paw and C57Bl/6J DNA. The clp mutation is identified, and 
further details are given in chapter 6.
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Mantık
Dağı tanıyan, nasıl tanımaz uçurumu?
Mademki yukseliş var, iniş olmaz olurmu? 
N. F. Kısakürek (Çile)
De logica
Een bergbeklimmer, weet als geen ander het bestaan van een ravijn
Indien er een stijging is, moet er ook een daling zijn
Vrije vertaling
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Postnatally the autosomal recessive mouse mutant clp/clp [1] can be selected based 
on the limb abnormalities, already present in utero [2]. Additionally, clp/clp mice are 
characterized by congenital hypomyelination of the peripheral nervous system.  
It is generally accepted that axonal contact-associated signals initiate the 
myelination process through coordinate activation of sets of genes. Myelin, a lipid-
rich insulation layer around axons, is the endpoint of Schwann cell differentiation. 
Although each Schwann cell has the potency to form myelin, yet unknown axonal 
signals determine whether myelination occurs [3-6]. The genetic cascade that 
is activated by these axonal contact associated signals include the transcription 
factors Oct-6 and Krox-20. Myelination is delayed in both Oct-6 [7-10] and Krox-20 
[11]  mouse mutants. Whereas the absence of the former results in a transient arrest 
of Schwann cell differentiation, the latter is essential during terminal differentiation. 
Hence Schwann cells of Oct-6 null mice eventually form normal myelin, whereas Krox-
20 null mutants remain devoid of myelin for the timepoints studied. Extensive analysis 
of these transcription factors revealed a genetical hierarchy within the myelination 
program where Oct-6 expression induces Krox-20 gene expression directly [12]. We 
have investigated the interaction between these transcription factors and the clp gene 
(chapter 3 and 4). Analysis of abnormal myelination in men and mice has resulted in 
the identification of several mutations in genes encoding proteins either required for 
myelin synthesis or axonal function. Thus dys-/demyelination does not necessarily 
mean that the Schwann cell is the defective cell type. In the past, impaired myelination 
in mice has been studied through nerve grafting experiments, which allows the study 
of regenerating axons in contact with genetically distinct Schwann cells. Analysis of 
remyelination (considered a reiteration of development) in the grafted nerve segment, 
indicates whether impaired myelination is due to an axonal or Schwann cell defect, 
or both [13-15].
To examine the role of the Schwann cell in dysmyelination as observed in 
clp mutants we studied Schwann cells during development and regeneration, as 
described in chapters 3 and 4. In these studies we provide evidence that clp/clp 
Schwann cells express Oct-6 normally in development, but are transiently inhibited 
to express successive genes involved in myelination. Although initially this would 
indicate that clp is a target gene of Oct-6, other findings are restricted to clp/clp 
Schwann cells such as delay in laminin and periaxin expression, suggesting a yet 
unidentified parallel role of clp in myelination process. Besides delayed expression of 
laminin, other proteins such as periaxin, myelin associated glycoprotein, P-zero are 
considered to be involved in cellular polarization.
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It seems as if clp/clp Schwann cells are transiently blocked during cell polarization 
(chapter 4). 
In order to be able to understand the hypomyelination observed in clp/clp peripheral 
nerves and its relation to limb posture abnormalities the gene has to be identified. 
Previous studies had already identified the position of clp in the mouse genome on 
chromosome 7 [1]. In order to find the clp gene, a positional cloning strategy was 
developed as described in chapter 5. A selection of anonymous markers surrounding 
clp region both on telomeric and centromeric site was made. Subsequently linkage 
analysis resulted in refining the clp area. Additionally, Fxyd3, Scn1b (genes involved 
in generation of membrane potential) and Mag (a myelin gene) mRNA expression 
were reduced in developing clp/clp nerves. Finally, while this thesis was written, 
our collaborators identified the clp gene. Clp turned out to be an insertion of 224 
basepairs, 5 nucleotides upstream of exon 4 of the Lgi-4 gene. 
Lgi proteins
Lgi-1 (leucine rich glioma inactivated-1), was cloned in a translocation breakpoint of a 
glioblastoma cell line [16]. Subsequently in silico mapping identified Lgi-2, Lgi-3 and 
Lgi-4 [16]. It was logical to assume a role for Lgi-1 in tumorigenesis, as the gene is 
strongly downregulated in malignant gliomas. Surprisingly, mutations in Lgi-1 were 
found to cause lateral temporal lobe epilepsy in several families with the disease. This 
was all the more surprising as genetic forms of epilepsy were invariably associated 
with mutations in genes encoding ion channels [17]. Therefore, it was assumed that 
Lgi-1 interacts with ion channels. 
LGI-proteins are constitutively secreted and functionally related to other 
protein families such as tyrosine kinase receptors and SLIT, which are involved in 
development and maintenance of the nervous system, in particular axon guidance 
[18]. 
Several domains can be recognized in Lgi proteins: 
1) a putative signal peptide
2) 3 LRR domains
3) 4 EAR domains
4) a putative N-linked GlcNac part
LRR repeat proteins
Cells of multicellular organisms are surrounded by extracellular matrix. The latter 
plays an essential role in many processes such as development, cell proliferation, 
differentiation, migration and adhesion. Among the extracellular matrix molecules 
there is a group characterized by its leucine-rich region (LRR) which dominates the 
structure of the core protein [19]. 
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LRR proteins have been found intercalated into the cell membrane as observed 
in tyrosine kinase family of neurotrophin receptors, attached to the cell membrane via 
a GPI-linkage and in the cytoplasm of the cell. This wide distribution of LRR proteins 
implicate diverse biological functions of LRR proteins [19]
EAR domain
Mutations in epilepsy-associated-repeat (EAR) have been identified in families with 
epilepsy [20]. For example mutations in the third EAR domain has been identified in 
idiopathic partial epilepsy syndrome. Additionally, this class of domains are thought to 
be involved in interactions between proteins [21]. 
A potential N-linked GlcNac part
Protein modifications through covalent linkage of sugars, phosphates, acetyl groups 
etcetera, is a common mechanism to regulate the function of a protein. These covalent 
modifications involve specific amino acid residues flanked by a loosely defined 
consensus sequence. For example, asparagines flanked by a serine or threonine is 
a potential site for glycosylation. N-glycans (linkage of N-acetylglucosamine with L-
asparagine) are involved in receptor sorting, ligand binding, dimerization of receptors 
and signal transduction [22]. Such a site is present in Lgi-4 and might be important 
for its function. However, whether it is used as a glycosylation site remains to be 
determined. 
Lgi-4 and claw paw phenotype
Do we understand the claw paw phenotype after the identification of the mutation in the 
Lgi-4 gene? Why would a mutation in a gene homologous to a tumor suppressor gene 
result in hypomyelination and arthrogryposis? It is too early to even begin to answer 
this question as virtually nothing is known about these proteins. Even their subcellular 
localization is unknown. All assigned functions to these proteins are guesses based 
on the domain structure of the proteins. A preliminary report has suggested that Lgi4 
and the other Lgi proteins are secreted proteins. However, expression of a myc-
tagged Lgi4 gene in COS cells suggest a vesicular localization of Lgi4 (unpublished 
observations of Martine Jaegle and Dies Meijer).
Lgi-4 has a leucine rich region, which is implicated in both axonal guidance 
and protein-protein interactions. Additionally, LRR proteins have been found at several 
places within the cell, attached or intercalated to the cell membrane and within the 
cytoplasm. Therefore it might be that impaired Lgi-4 expression is disturbing axonal 
guidance and protein-protein interactions at various places within the cell or between 
two celltypes. 
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Lgi-4 was cloned and a susceptibility allele (polymorphism) within this gene was 
identified for childhood absence epilepsy [23]. 
Furthermore, predominantly the epilepsy associated repeat (EAR) domain is 
mutated in epilepsy. This domain is associated with ligand recognition of the receptor 
and protein protein interactions. Its absence may influence protein interactions and 
signaling via the receptor.  
Silencing of gene expression is regulated in several manners in the human 
genome. One  known post-transcriptional silencing mechanism is the formation of 
antisense RNA. Antisense RNA can be formed when two distinct genes overlap at 
the DNA level, and are transcribed from opposing DNA strands. When both genes 
are expressed in the same cell-type at the same time, it is possible that the two 
RNA’s bind to each other and influence further processing and translation. This might 
result either in absence or reduced protein levels of the respective genes. Lgi-4 and 
Fxyd3 are genes that overlap at the 3’ end, have a reverse orientation and indeed are 
expressed in the same tissues at the same time. Potentially it is possible that RNA 
from these genes bind to each other and interfere with gene expression [24]. 
Future perspectives
With the identification of the clp gene we can finally begin to investigate the underlying 
cellular defects in clp/clp mice through detailed study of the function of the Lgi-4 
protein and possibly provide an explanation for the remarkable link between congenital 
hypomyelination and limb contractures observed in clp/clp mice. First, it is important 
to generate antibodies for Lgi-4 to determine the localization of this protein and to 
start to study its function. Additionally, it is preferred to generate a knock-out with the 
identified mutation to see whether claw paw phenotype is observed.
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Based on anatomical and functional grounds, the nervous system is usually described 
to consist of two components: the central (brain and spinal cord) and peripheral 
nervous system (motor and sensory nerves, sensory ganglia, sympathetic and para-
sympathetic ganglia and nerves and the enteric nervous system). A large proportion 
of nerve fibers in both systems is covered with a lipid rich membranous layer (myelin), 
which allows fast impulse propagation at low energy costs. Myelin is formed in the 
central nervous system and peripheral nervous system by oligodendrocytes and 
Schwann cells respectively. Work described in this thesis focuses on the genetics 
and cell biology of myelin formation ( myelination) in the peripheral nervous system. 
The formation of the myelin sheath represents the last stage of Schwann cell 
differentiation, a process that starts with the generation of Schwann cell precursors 
from the neural crest. The proliferation, migration and differentiation of Schwann 
cell precursors into myelinating Schwann cells requires the differential recruitment 
of genetic information contained within the chromosomes of the cell. A number of 
nuclear proteins that play an important role in this differential recruitment of genetic 
information have been studied in detail over the last decade. In particular, it has been 
demonstrated that the transcription factors Oct-6 and Krox-20 are involved in the 
promyelin to myelinating transition and myelination respectively. In the absence of 
Oct-6, Schwann cells transiently arrest at the promyelin stage of cell differentiation, 
while in the absence of Krox-20 Schwann cells fail to initiate myelin formation. In 
addition to these engineered mouse mutants, natural mouse mutants have been 
characterized in which peripheral nerve myelination is affected. One such natural 
mouse mutant is the claw paw (cp/clp) mouse. Clp/clp mice are characterized by 
non-fixed limb abnormalities at birth (in clinical practice referred to as arthrogryposis; 
arthron = “joint” and gryposis = “bent”) and congenital hypomyelination of the PNS 
with delayed onset of myelination. We choose to study this mouse mutant in detail for 
a number of reasons. First, the similarities in genetics and peripheral nerve phenotype 
between clp/clp and Oct-6 mutants suggest a possible interaction between these 
genes. Second, the combination of limb abnormalities and congenital hypomyelination 
suggest a common neurogenic origin and third, the clp/clp mouse serves as a mouse 
model for the human syndrome of arthrogryposis multiplex congenita with congenital 
hypomyelination.
1) To shed light on these and related issues, we addressed two key questions 
in this thesis: what cell type is affected by the clp mutation and how does this 
mutation affect Oct-6 and Krox-20 in Schwann cells?
2) what is the underlying genetic defect of the claw paw phenotype?
In chapter 2 I describe the experimental approach chosen to answer these questions. 
In chapters 3 and 4 experiments are described that demonstrate that the clp gene is 
cell-autonomously required in Schwann cells and possibly in neurons. Furthermore, 
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we show that the clp defect affects radial sorting of nerve bundles suggesting an 
impairment of axon-Schwann cell interactions and cellular polarization. In chapter 
5 I describe our positional cloning efforts that resulted in the definition of a minimal 
critical region in which the clp gene resides. Chapter 6 contains a general discussion 
of the work and suggestions for future directions.
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Gebaseerd op functionele en anatomische gronden wordt het zenuwstelsel onderver-
deeld in twee componenten: centraal (brein en ruggemerg) en perifere zenuwstelsel 
(motore en sensore neuronen en ganglia, sympatische en parasympathische ganglia 
en zenuwen).  Het merendeel van de zenuwen in beide systemen worden omgeven 
door een vetrijke isolatielaag welke myeline wordt genoemd. Myeline wordt in het 
centraal en perifeer zenuwstelsel gevormd door respectievelijk oligodendrocyten en 
Schwann cellen. De myeline laag rondom axonen is van cruciaal belang voor het 
functioneren van het zenuwstelsel. Afbraak van myeline leidt tot ernstige neurologi-
sche problemen zoals in multiple sclerose en de erfelijke perifere neuropathiën. In dit 
proefschrift wordt werk beschreven dat tot doel had een aantal genetische en celbio-
logische aspecten van myelinisatie in het perifere zenuwstelsel op te helderen.
De vorming van myeline is het laatste stadium van een differentiatie proces 
van de Schwann cel dat begint met de emigratie van dorsale neuro-epitheliale 
cellen uit de neuraalbuis. Deze migrerende populatie cellen wordt de neurale lijst 
genoemd. In een vroeg stadium van de ontwikkeling associëren neurale lijst cellen 
met de uitgroeiende axonen. Deze zogenaamde Schwann cel voorlopers prolifereren 
en differentiëren uiteindelijk tot myeline vormende Schwann cellen. Celdifferentiatie 
vereist de gereguleerde expressie van een set genen die belangrijk zijn voor 
de specifieke vorm en functie van de cel. De expressie van deze genen wordt 
gereguleerd door een klasse van DNA bindende eiwitten welke transcriptiefactoren 
worden genoemd. Een aantal transcriptiefactoren die een belangrijk bijdrage leveren 
aan Schwann cel differentiatie zijn de laatste decennia gedetailleerd bestudeerd. Uit 
dit werk  bleek dat twee transcriptiefactoren, namelijk Oct-6 en Krox-20, van belang 
zijn voor respectievelijk de overgang van het promyeline naar myeline stadium en 
myelinisatie. Terwijl in afwezigheid van Oct-6 myelinisatie tijdelijk geblokkeerd is in 
het promyeline stadium, wordt er totaal geen myeline gevormd in afwezigheid van 
Krox-20. 
Naast deze muize mutanten die door genetische modificatie ontstaan zijn, 
zijn er ook spontane mutanten bekend die een gestoorde myelinisatie vertonen. Een 
voorbeeld is de muis mutant claw paw (clp). Clp/clp muizen worden gekarakteriseerd 
door pootafwijkingen (in de kliniek wordt dit beschreven als arthrogryposis; 
arthron=joint and gryposis=gebogen) en congenitale hypomyelinisatie gebaseerd op 
vertraagde myelinisatie. Deze muis werd om een aantal redenen uitgekozen voor 
nader onderzoek. Ten eerste; de genetische en neuropathologische overeenkomsten 
tussen clp/clp en Oct-6 mutanten suggereren een interactie tussen deze genen. Ten 
tweede; de combinatie van arthrogryposis en congenitale hypomyelinisatie suggereert 
een gemeenschappelijk neuronale oorzaak van het fenotype.
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Ten derde; de clp/clp muis kan als model gebruikt worden om de relatie tussen 
arthrogryposis en congenitale hypomyelinisatie beter te begrijpen.
Om inzicht te verkrijgen in deze en andere gerelateerde vraagstukken, hebben 
we onszelf twee vragen gesteld: 
1) welk celtype is defect door de clp mutatie en hoe worden de
    transcriptiefactoren Oct-6 en Krox-20 hierdoor beïnvloed?
2) Wat is de genetische oorzaak die resulteert in dit fenotype?
In hoofdstuk 2 beschrijf ik de gekozen experimentele benadering om op deze vragen 
een antwoord te geven.
In hoofdstuk 3 en 4 worden experimenten beschreven die aantonen dat het clp gen 
functioneert in Schwann cellen en mogelijk in neuronen. Verder tonen we aan dat 
het clp defect resulteert in een vertraagde axonale rangschikking door Schwann 
cellen, mogelijk als gevolg van verstoorde axon-Schwann cel interactie en cellulaire 
polarisatie.
In hoofdstuk 5 beschrijf ik de afbakening van een kritische regio waarin het clp gen 
moet liggen, door middel van ’linkage analysis’.
Hoofdstuk 6 omvat een discussie van het werk en suggesties voor verder 
onderzoek.
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Annelies, Margreet, Liesbeth, Esther), de DNA-diagnostiek (Wilma, Norma, Ans, 
Dicky, Henny, Dennis, Pino en vele anderen) allen bedankt. 
De kleine commissie Chris, Niels en Bert wil ik danken voor de suggesties. 
Natuurlijk wil ik Tom bedanken voor de lay-out van dit proefschrift. En Ruud? 
Bedankt.  
Vaak schuilt achter het werk, een front waarop je terug kunt vallen, vrienden. 
Bedankt voor jullie onuitputtelijke en oprechte vriendschap. Alhoewel ik liever geen 
onderscheid maak tussen mijn vrienden (Talip, Metin, Nuray, Türkan, Yavuz, Emine, 
Nazik, Bilge, Özgür en vele anderen) ben ik wel genoodzaakt om een selectie te 
maken voor de paranimfen. Metin bij jou, je vrouw (Rabiş) en je familie voel ik me 
goed, bedankt. 
Ja Nuray, over jou kan ik boeken volschrijven, maar dat is niet de bedoeling. 
Vanuit het diepste van mijn hart dank je wel. 
Nuray, Emine, Yavuz, Nienke en Nuray Başalan wil ik danken voor de hulp bij 
de vertaling van de gedichten, waarbij vrije vertaling staat, uiteindelijk is het vaak een 
combinatie geworden. Nuray hanim, beni tanımadan bana yardım ettiğiniz için, size 
gönülden teşekkürler.
Mehmet bey, benim düşüncelerimi gercekleştirdiğiniz için size minnettarım. 
En natuurlijk een front, waarin je het nooit bont kunt maken, ouders. Bij deze 
wil ik mijn ouders en zus danken voor alle steun die ik van ze krijg bij wat ik ook doe. 
Anne, baba ve abla. Sizlerin varlığı, desteği, duaları, güleryüz ve tatlı sözleriniz 
olmasaydı ben galiba bunların hiçbirini yapamazdım. En içten duygularımla size 
teşekkür etmek istiyorum. Sevgi ve saygılarımla ellerinizden öpüyorum. Ve Türkiyede 
olan bütün akrabalarımın manevi desteği içinde çok teşekkürler.  
Dankwoord
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Exons of selected genes DNA sequence Annealingstemperature
Amplified
product size
fxyd3exon1 sense TTAAgggAggAATggAgTggg 61 310
fxyd3exon1 anti sense AgCAgAggCTCAgggAggAA 61 310
fxyd3exon2 sense TggTgAgCAACAggTgAgACA 61 419
fxyd3exon2 anti sense gAgAgAgAgTCTgCCCgTTgA 61 419
fxyd3exon3-4 sense AACCTCCATggATCCggCT 61 401
fxyd3exon3-4 anti sense ACTgAgCAggACgggAAgAA 61 401
fxyd3exon 5-6 sense AAgggCCTgggTTTgCTTT 58 444
fxyd3exon 5-6 anti sense TCgggATgATTTgCCACA 58 444
fxyd3exon 7-8 sense ACAgTgggAAACCAgCCAAg 65 582
fxyd3exon 7-8 anti sense gCCTCACTCCAAgCTCCACA 65 582
Scn1bexon1 sense gCCTCggAATTggTgTATgg 55 1374
Scn1b exon1 anti sense gATCCTTCTgTgCCgTCCA 55 1374
Scn1b exon2 sense AgTgACATCCTCTTTCCCAgg 54 679
Scn1b exon2 anti sense ATgCACTCAgACAAgCCAATC 54 679
Scn1b exon3 sense gggAACAggTTgggAATgg 61 413
Scn1b exon3 anti sense TgTTAgCTggCCTCTgTgTgg 61 413
Scn1b exon4 sense ACTTgCCCgAgCTCACACA 61 401
Scn1b exon4 anti sense TTCgAgTTgCggCTTTgC 61 401
Scn1b exon5 sense ggCAgAgTTACAgCTTgTCgg 55 367
Scn1b exon5 anti sense AAgAgTgTgTCCCTgAgCCCT 55 367
Scn1b exon 6 sense AgggCTCAgggACACACTCTT 61 614
Scn1b exon 6 antisense AAgAgAggAggCCgAAgAgg 61 614
fxyd7 exon 1 sense TCAgTgCCTCTTgTgCgAAA 55 396
fxyd7 exon 1 anti sense TCgTCTTCCTTTCCgTATggg 55 396
fxyd7 exon 2 sense TTggTCCATCTTgCTCCTCAA 55 298
fxyd7 exon 2 anti sense ggTTCACAgCCTTCATCAggg 55 298
fxyd7 exon 3 sense ggAggTgAgAATCCAgAAggg 55 399
fxyd7 exon 3 anti sense gCAggCAgAggACCTTCAAg 55 399
fxyd7 exon 4-5 sense TTgAgggTTTCCTgCTggTC 55 437
fxyd7 exon 4-5 anti sense TCCgAggCTTgCATTTCTTT 55 437
fxyd7 exon 6 sense gCAgCCATCCTTggACTCTg 65 510
fxyd7 exon 6 anti sense gACAgTCAACTCAgCCTCCCA 65 510
Appendix
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  1. De wederzijds afhankelijke functie en differentiatie van verschillende celtypen 
binnen een weefsel bemoeilijkt de identificatie van het celtype dat is aangedaan 
door een genetisch defect.
 Dit proefschrift
  2. Verstoorde cellulaire communicatie tussen neuron en glia cel leidt tot vertraging 
in differentiatie.
 Dit proefschrift
  3. Polarisatie is een van de eerste stappen in het cellulaire differentiatieproces.
 Dit proefschrift
  4. Positioneel kloneren is iets uit de oude doos: rechtstreeks sequencen van het 
genoom is de snelste weg naar identificatie van genetische afwijkingen.
 Dit proefschrift
  5. Om vanuit het fenotype het defecte gen te voorspellen binnen een kritische regio 
blijft een hachelijke onderneming.
 Dit proefschrift
  6. De term ‘Junk’ DNA blijkt achteraf een ongelukkig gekozen term.
 S. Brenner Nature’s Gift to Science Nobel lecture 2002
  7. The world is full of willing people; some willing to work, the rest willing to let them.
R. Frost 
  8. The noblest pleasure is the joy of understanding.
 L. da Vinci
  9. Education makes a people easy to lead, but difficult to drive; easy to govern but 
impossible to enslave.
 Baron Henry Peter Brougham
 
10. We must not believe the many who say that only free people ought to be educated, 
but we should rather believe the philosophers who say that only the educated are 
free.
 Epictetus
11. Ondanks dat vandaag de dag onafhankelijkheid wordt nagestreefd, zijn we 
massaal afhankelijk van de computer.
Stellingen
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